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Abstract
Optical mapping is a fluorescence based imaging technique used extensively
in cardiac research to study the electrophysiological properties of isolated
hearts kept at physiological conditions. The major limitation of optical map-
ping studies are the distortions of electrophysiological signals due to the
contractile motion of the hearts. To reduce electrophysiological signal dis-
tortions due to the contractile motion artifacts, the mechanical motion has
been suppressed in optical mapping experiments using electromechanical
uncouplers such as Blebbistatin. Recent studies used marker-free numerical
motion tracking and motion stabilization techniques to record electrophys-
iological parameters in the absence of electromechanical uncouplers and
showed that contractile motion of the cardiac tissue is no longer a limitation
in optical mapping studies. However, despite these developments, accurate
measurements of quantities such as action potential duration (APD) and
cardiac restitution are still challenging due to the residual motion artifacts
present in the electrophysiological signals even after numerical motion track-
ing.
A combination of marker-free motion tracking and ratiometric optical
mapping technique is used in this thesis to minimize motion-related artifacts
from contracting hearts. This combined experimental and numerical tech-
nique reduced motion artifacts significantly and hence, the combination is
used to precisely measure APD, cardiac restitution and ventricular fibrillation
frequencies from Langendorff perfused contracting and deforming rabbit
hearts. A systematic comparison of these electrophysiological parameters
in contracting and Blebbistatin-uncoupled conditions showed, on average,
27± 5% (N=5 hearts) shortening of APD in contracting hearts as compared
to Blebbistatin-uncoupled hearts. Ventricular fibrillation frequency signif-
icantly increased in contracting hearts (13 ± 3.5 Hz) in comparison with
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The heart is a vital organ in the human body responsible for pumping blood
in an efficient manner. An adult heart pumps about 6000-7500 liters of blood
daily hence making the life possible. At the cellular level, the mechanical con-
traction of the cardiomyocyte (heart muscle cell) is triggered by the cardiac
action potential, which is a brief change in membrane potential across the cell
membrane of cardiac cells. A rapid positive change in membrane potential
(depolarization) is followed by a plateau phase and it finally followed by a
slow decrease in membrane potential (repolarization). The action potential
triggers the release of calcium stored in the Sarcoplasmic Reticulum (SR) and
the calcium released from the SR triggers the mechanical contraction of the
cardiomyocyte. This entire process in which electrical excitation produces
mechanical contraction through the release of calcium is called excitation-
contraction coupling (ECC). Multiple studies [Sir96; Fra96; Fra00] show that
electromechanical interactions are bidirectionally coupled such that in addi-
tion to excitation-contraction coupling, mechanical perturbations of the heart
can produce electrical excitations through a process called mechano-electric
feedback (MEF). Studies of these electromechanical interactions are essential
in understanding lethal cardiac arrhythmias such as ventricular fibrillation
(VF).
A widely used non contact technique to study electrical excitation of the
cardiac tissue is called optical mapping (basic overviews can be found in
[Min11; ENS04]). Optical mapping is a fluorescence imaging technique
used extensively in cardiac research to image and visualize electrophysi-
ological properties such as action potential [SC00], intracellular calcium
concentration [Nid+98; Ven+12] or both [LS01; Lee+12] from the surface
of isolated hearts kept at physiological conditions. Optical mapping is used
to obtain high spatial and temporal resolution of action potential or calcium
concentration signals from the surface of the heart by loading it with fast
responding voltage or calcium sensitive fluorescent dyes. Upon excitation
with proper wavelength of light, the fluorescent emission from these dyes
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undergo intensity modulation due to the electrophysiological quantities un-
der study. For example, voltage sensitive fluorescent dyes undergo a spectral
shift upon depolarization of the cardiac tissue with action potential upstroke.
These fluorescent emissions containing the information of action potential
or calcium concentration are captured by a high resolution camera. Though
optical mapping is considered as the gold standard technique during the
past 25 years, like all other techniques, optical mapping also has limitations.
Optical mapping studies are highly susceptible to motion and even a small
motion of the heart tissue can distort the fluorescence signal captured on the
detector. This so called motion artifacts are the biggest challenge in optical
mapping studies involving beating hearts.
To overcome the difficulties of motion artifacts, until recent times, all
optical mapping studies were carried out by suppressing the mechanical
contraction of the heart by using either mechanical constraints or with
the help of pharmacological electromechanical uncouplers such as DAM
[Liu+93], Cytocholasin-D [Ket+04b] , Blebbistatin [Fed+07] etc. These
uncouplers uncouple the electrical and mechanical activity by suppressing
the contractile motion. This enables the measurement of action potential
and calcium concentration from the cardiac surface which are free from
motion artifacts. Among these pharmacological uncouplers, Blebbistatin is
the most commonly used uncoupler in optical mapping studies for the last
10 years and it is considered as the most reliable pharmacological agent with
minimal effects on cardiac electrophysiology [Fed+07]. However, studies
involving Langendorff perfused hearts (detailed description in Chapter 2)
show variations in electrophysiological properties such as action potential
duration with Blebbistatin [Bra+13; Lee+19]. Apart from that, suppressing
the mechanical contraction is not physiological and it does not allow the study
of electromechanical interactions simultaneously. Recently, numerical motion
tracking and motion compensation algorithms were developed to track and
compensate the contractile motion of the cardiac tissue with polyethylene
markers [Bou+11; Zha+16] and also without using markers to track and
stabilize the contractile motion in optical mapping studies [CL18; CSSL17].
Marker-free motion tracking was also combined with ultrasound imaging to
study and characterize the chaotic wave pattern of ventricular fibrillation
from contracting rabbit hearts [Chr+18].
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However, precise measurement of electrophysiological parameters such
as action potential duration (APD) and electrical restitution (variation of
APD with heart rate, also called APD restitution) from a contracting heart in
optical mapping studies are still challenging due to residual motion artifacts
present in the action potential signals even after tracking and stabilizing the
contractile motion. Accurate measurements of these properties are highly
important since APD alternans (beat to beat variations in APD) [Kar93;
Kar94] and APD restitution [Xie+04; Ng16; Mon14] have dynamical con-
sequences in the arrhythmogenicity of the heart. Also, drugs which reduce
restitution slope such as bretylium, verapamil, and diacetyl monoxime (DAM)
are shown to have antiarrhythmic behavior [Wei+02; RKG99]. Hence to
measure the important electrophysiological properties of contracting hearts
precisely, the residual artifacts need to be reduced. The main reasons for
these residual artifacts are the spatial variation of local light intensity and
spatio-temporal variation of local dye concentration within the heart, which
cannot be removed by motion tracking alone. Ratiometric optical mapping
addresses these limitations by canceling the common artifacts present in
the electrophysiological signal [Bac+11]. Hence, this thesis focuses on the
combination of marker-free motion tracking and ratiometric optical mapping
technique with the following goals:
1. Combining ratiometric optical mapping and marker-free motion tracking
to obtain optical action potential signals with reduced motion artifacts.
2. Precise measurement of APD and electrical restitution from contracting
hearts.
3. Systematic comparison of APD and electrical restitution of the contracting
hearts with that of non-contracting hearts (electromechanically uncoupled
with Blebbistatin)
4. Comparison of arrhythmic dynamics, more specifically ventricular fibrilla-
tion in contracting and uncoupled hearts.
The entire thesis is divided into 7 chapters including the introductory
chapter. In chapter 2, background information about cardiac electrophysiol-
ogy including Langendorff perfusion setup, electromechanical interactions,
optical mapping technique to measure the electro-physiological quantities
and the challenges of optical mapping techniques are shown. Chapter 3
shows the detailed description of ratiometric optical mapping experiment.
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Chapter 4 focuses on motion artifact reduction techniques such as numerical
motion tracking, ratiometry and the combination of both. Chapter 5 uses
combined motion tracking and ratiometric techniques with a beating heart
to precisely measure action potential duration (APD) and also to compare
APD restitution curves of contracting and contraction inhibited (by the ad-
ministration of Blebbistatin) hearts. Chapter 6 compares the dynamics of
ventricular fibrillation in contracting and contraction inhibited hearts by mea-
suring the dominant frequency of optical action potential signals using the
combination of motion tracking and ratiometry. Chapter 7 summarizes the
obtained results, limitations of the techniques used and also discuss possible
improvements for the future.




2.1 Electrical conduction system of the heart
The mechanical contraction of the heart chambers are triggered by electrical
impulses (action potentials) originating from the sinoatrial (SA) node situated
at the right atrium of the heart. The SA node undergoes self excitation and
produces electrical impulses in a regular interval, hence it is called the natural
pacemaker of the heart. The electrical impulses from the SA node excite the
right atria and travels through the interatrial pathway to excite the left atria
and trigger atrial contraction. The electrical impulses then propagate to the
ventricles through the atrioventricular (AV) node. The AV node slows down
the propagation of electric current to ensure that atria contract fully before
ventricular excitation. After entering the ventricle, the electrical impulses
further propagate through left and right bundle branches and finally through
Purkinje fibers to trigger the contraction of left and right ventricles.
2.2 Cardiac arrhythmia
Cardiac arrhythmias (also known as heart rhythm disorders) are the mal-
functioning of the electrical activity of the heart. This abnormal electrical
activity causes abnormal contraction of the heart in contrast to the normal
rhythm (sinus rhythm). There are mainly two types of cardiac arrhythmia:
bradyarrhythmia and tachyarrhythmia. Bradyarrhythmia is a condition of the
heart in which the heart rate becomes very low as compared to the normal
heart rate (60-100 beats per minutes in human, athletes are exceptions).
Tachyarrhythmia is characterized by fast heart rates. For an adult human,
heart rates less than 60 beats per minute are considered as bradyarrhythmias
and heart rates higher than 100 beats per minute are called tachyarrhythmias.
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Fig. 2.1: Electrical conduction system of the heart. Electrical impulses originating
from the SA node spread across the right and left atria and are responsible
for atrial contraction. These impulses then propagate through the AV
node to the ventricles, and propagate further through bundle branches
and Purkinje fibers and finally trigger the ventricular contraction. Image
reproduced from [Gan+07], Licence: Creative Commons Attribution 3.0.
Ventricular fibrillation (VF) is the most lethal tachyarrhythmia characterized
by fast and irregular electrical activity in the lower chambers of the heart
(ventricles). These electrical activities produce non coherent contraction in
different parts of the cardiac tissue, hence the effective pumping power is
lost. VF can cause sudden cardiac arrest within a short interval of time if
untreated. Figure 2.2 shows exemplary time traces of optical action poten-
tials obtained during normal and abnormal (here, ventricular fibrillation)
heart rhythms. The sinus rhythm consists of regular and low frequency (here,
frequency < 2 Hz) action potential signals, whereas ventricular fibrillation
is characterized by fast (here, frequency ≈ 9 Hz) and irregular action poten-
tial time traces. In addition to the difference in temporal variations of the
action potential signal, there are also notable differences in action potential
wave propagation during normal and abnormal heart rhythms. The electrical
activity propagates as a planar wave of excitation across the heart tissue
during normal sinus rhythm, whereas electrical excitation of the heart during
ventricular fibrillation consists of spatio-temporal chaos.
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Fig. 2.2: Optical action potential time traces showing the variation of action poten-
tial modulated normalized fluorescent intensity (Inorm) for normal (sinus
rhythm) and abnormal (ventricular fibrillation) heart rhythms. The time
traces were extracted from the left ventricular surface of a rabbit heart.
The contraction of the heart was inhibited by Blebbistatin. The time traces
were spatio-temporally filtered with a window size of 3× 3× 3 (average
of 3× 3 pixels and 3 frames). Ventricular fibrillation is induced by high
frequency electrical pulses with the help of a stimulating electrode placed
on the surface of the heart.
2.3 The Langendorff perfused hearts
Langendorff perfused hearts, introduced in 1895 by Oscar Langendorff are
isolated perfused mammalian hearts used widely in cardiac research to
keep the hearts alive in a specific physiological conditions outside the body
[BMY11]. Langendorff perfused hearts have been used to study myocardial
physiology and contractility among a wide range of species including mice,
rat, rabbit, dog, pig and human. All experimental studies in this thesis used
Langendorff perfused rabbit hearts.
In a Langendorff perfusion setup as shown in Figure 2.3, the excised
animal heart is perfused in a retrograde fashion via the aorta using Tyrode’s
solution. The solution provides the necessary nutrients and oxygen to the
heart to keep it alive for many hours (usually 4-8 hours) in a physiological
condition similar to blood. The Tyrode’s solution is usually bubbled with
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carbogen containing 95% oxygen and 5% carbon dioxide to ensure enough
oxygen and a physiological PH value (≈ 7.4) to the heart. This solution is
preheated and pumped into the bubble trap through a heat exchanger. The
heart is connected directly below the bubble trap by the cannulation of aorta,
which closes the aortic valve upon perfusion and hence, the perfusate passes
through the coronary vasculature and nourishes the heart. The perfused
heart is allowed to hang in a bath containing a heating facility, to maintain
the required physiological temperature (37° C). The Langendorff perfusion
setup is comparatively simple and can be used to add drugs and fluorescent
dyes to the heart without many complications. Also, the electrophysiological
parameters such as electrocardiogram (ECG) and optical action potential etc.
can be measured with ease in a Langendorff perfusion setup.
100/200 V amplifier
ECG / MAP recording
95% O2, 5%CO2
heat exchanger





Fig. 2.3: Schematic of Langendorff perfused heart. The extracted heart from the
animal is kept submerged in a perfusion bath containing Tyrode’s solution.
Voltage sensitive or calcium sensitive fluorescent dyes can be provided to
the heart tissue through the bubble trap in a retrograde fashion. LEDs and
camera are used for optical mapping and ECG signals are captured with
a combination of ECG electrodes and an amplifier. Two pedal electrodes
connected to a 100/200 V amplifier are used to provide electrical shocks
to terminate arrhythmias (defibrillation). Sketch from [Hor13].
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2.4 Study of electromechanical interactions
The interactions between electrical and mechanical activities of cardiac mus-
cle cells are bidirectional phenomena (an overview can be found in [PT14])
in which electrical excitation of the cardiomyocyte triggers its mechanical
contraction through excitation-contraction coupling (ECC) and mechanical
perturbation produces electrical depolarization through a process called
mechano-electric feedback (MEF). Hence, simultaneous measurement of
electrical and mechanical activities of the heart can provide useful infor-
mation regarding these complex electromechanical interactions. However
these electromechanical properties often vary spatially (across the heart)
and temporally. For example, ventricular fibrillation dynamics as mentioned
before shows spatio-temporal chaotic activities. Despite active research, elec-
tromechanical interactions of a beating heart are still not fully understood
mainly due to the technical difficulties to precisely measure both electrical
and mechanical properties of the beating heart simultaneously from multiple
locations of the heart tissue. Though optical mapping provides a smart way
of measuring electrical activity from multiple locations of the cardiac tissue,
often mechanical contraction is uncoupled from electrical excitation by using
pharmacological agents to reduce artifacts originating from the contractile
motion. However, recent studies [Bou+11; Zha+16; CSSL17; CL18] used
numerical post processing algorithms to track the contractile motion of the
cardiac tissue and showed that optical mapping can be performed in beating
and moving hearts.
2.4.1 Excitation-contraction coupling
Excitation-contraction coupling (ECC) is the process by which electrical exci-
tation of the cardiac muscle cell causes its mechanical contraction through
the release of calcium (Ca2+) stored in the sarcoplasmic reticulum (situated
within the cells). The release of Ca2+ from the sarcoplasmic reticulum is
triggered by the intake of Ca2+ into the cell as a result of an action poten-
tial depolarization. This process is called calcium induced calcium release
(CICR) [Cal92] and it is essential for the contraction of cardiomyocytes. Ca2+
released from the sarcoplasmic reticulum binds to a protein called troponin,
which is bound to the actin myofilament. Upon binding of Ca2+, troponin un-











































Fig. 2.4: Example of excitation-contraction coupling. Cardiac action potential (AP;
red) triggers the increase in intracellular calcium concentration (calcium;
green), which finally triggers the mechanical contraction (contraction;
black) of the heart muscle. Time series obtained from the left ventricular
surface of a rabbit heart during sinus rhythm in an optical mapping ex-
periment. The time traces were spatially averaged from 3× 3 pixels. The
heart was loaded with Di-4-ANBDQPQ (voltage sensitive dye) and Rhod-2
AM (calcium sensitive dye) to measure action potential and intracellular
calcium concentration simultaneously.
dergoes a conformational change which allows another myofilament, myosin
to attach to the actin and causes cell contraction. The mechanism of ex-
citation contraction coupling can be visualized by using optical mapping
experiments (see section 2.5) involving beating hearts with the help of volt-
age and calcium indicators to record action potential, intracellular calcium
concentration (increases as a result of CICR) from contracting hearts. An ex-
ample of excitation-contraction coupling is shown in Figure 2.4. Time traces
show cardiac action potential (AP; red), intracellular calcium concentration
(calcium; green) and amplitude of contractile motion (contraction; black)
obtained with optical mapping (see section 5.4 for motion amplitude calcu-
lation details). Action potential causes an increase in intracellular calcium
concentration (due to the release of calcium from sarcoplasmic reticulum)
and the increase in calcium triggers the mechanical contraction of the muscle
by activating the myofilaments.
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2.4.2 Mechano electric feedback
Studies in animal hearts show that mechanical perturbations such as stretch
of the myocardial tissue can cause electrical depolarization of the tissue. This
mechanism is known as mechano electric feedback (MEF) or contraction
excitation coupling [Fra96; Sir96]. For example, blows to the chest can alter
myocardial stretch or pressure loading prior to or during electrical activation.
The MEF together with ECC make the coupling between electrical excitation
and mechanical contraction bidirectional. MEF is shown to promote cardiac
arrhythmias [Fra96; Sir96]. A rare disease Commotio cordis was observed to
cause ventricular fibrillation and sudden cardiac arrest. It is initiated by a
localized precordial impact that is not sufficiently strong to cause mechanical
damage to the heart or surrounding organs [PT14].
2.5 Optical mapping of cardiac
electrophysiology
Optical mapping is a fluorescence imaging technique in which voltage sensi-
tive and calcium sensitive fluorescent dyes are used to map action potential
and calcium concentration optically from the cardiac tissue. Upon excitation
with proper wavelengths, these fluorescent dyes emit fluorescent light which
is modulated by the change in membrane potential or by the change in
calcium concentration. Since these cardiac activities occur on a millisecond
time scale and the change in fluorescent intensity due to them is very small
(usually 2-10% of fractional change in intensity for a change in cell mem-
brane potential of 100 mV), optical mapping techniques use cameras with
high speed and high quantum efficiency.
Potentiometric or voltage sensitive dyes bind to the cardiac cell membrane
and shift the wavelengths of absorption or emission with cardiac action
potential (see section 3.1.1 for spectral properties of a voltage sensitive dye).
The calcium sensitive fluorescent dyes in general show an acute increase
or decrease in their fluorescence intensity upon binding of Ca2+. When
Ca2+ binds to a ratiometric calcium sensitive dye, it changes the optimum
excitation or emission wavelength of the dye [Boo+13].
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Fig. 2.5: Multi-parametric optical mapping setup illustrating simultaneous imaging
of action potential and calcium concentration from a rabbit heart. The
rabbit heart kept in a Langendorff perfusion is loaded with voltage sensitive
(Di-4-ANBDQPQ) and calcium sensitive (Rhod-2 AM) fluorescent dyes.
The fluorescent emission from these dyes shows modulation in intensity
due to cardiac action potential and intracellular calcium concentration.
The action potential and calcium dependent fluorescent emission are
captured by an EMCCD camera equipped with a dual band pass emission
filter. The excitation light is switched with each camera frame such that the
fluorescent emission captured on the camera can be separated into optical
action potential and calcium concentration by using odd-even camera
frames.
Figure 2.5 shows an optical mapping setup used to measure cardiac ac-
tion potential and calcium concentration simultaneously from a Langendorff
perfused rabbit heart. The heart is stained with fluorescent dyes which are
sensitive to voltage and calcium. Voltage sensitive dye Di-4-ANBDQPQ (red
excitation (620-660 nm) and red emission (≈700 nm)) is used for action
potential recordings, whereas calcium sensitive dye Rhod-2 AM (green exci-
tation (552 nm) and yellow emission (581 nm) is used for the recording of
calcium concentration. The fluorescent emission containing the information
of action potential and calcium concentration are recorded with an EMCCD
camera having a dual band pass emission filter (580± 25 nm+ 800± 100 nm)
attached with it. The excitation light is synchronously switched with each
camera frame so that odd frames of the camera capture fluorescent intensity
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changes with one excitation wavelength and the even frames record fluores-
cent changes with the second excitation wavelength. That is, odd frames
record fluorescent intensity modulation with action potential/calcium from
the cardiac tissue and even frames capture fluorescent intensity modulation
with calcium/action potential. The example shown in Figure 2.4 used voltage
sensitive dye Di-4-ANBDQPQ for action potential measurement and calcium
sensitive dye Rhod-2-AM for calcium concentration measurement.
It is to be noted that, depending on the optics used, optical mapping can
obtain high spatial and temporal resolution action potential and calcium
concentration signals from isolated hearts kept at physiological conditions.
However, this thesis is designed to focus on optical mapping techniques
specific to action potential recordings and the measurement of important
electrophysiological parameters from Langendorff perfused contracting rabbit
hearts.
2.5.1 Motion artifacts
The mechanical contraction of the heart is very important for efficient pump-
ing of blood to other organs of the body. Although the above pumping
mechanism is absent in Langendorff perfused hearts, the hearts can still con-
tract and cause mechanical deformation and displacement of the tissue. This
mechanical contraction can lead to distortions of measured action potential
or calcium concentration signals (also in wave propagation) in optical map-
ping experiments. These distortions due to mechanical motion are generally
referred to as motion artifacts.
As illustrated in Figure 2.6 A, the motion artifacts mainly arise due to three
reasons:
1. Relative motion between the cardiac tissue and the detector: The
contractile motion of the cardiac tissue with respect to the camera results in
loss of correspondence between the camera pixel and a particular part of the
cardiac tissue. In this case, the electrophysiological signals (optical action
potentials) captured by the camera pixel contain the information from more
than one location, which causes distortions in the recorded signals.
2. Inhomogeneous illumination: Motion of the cardiac tissue through an
inhomogeneous light field contributes to distortion in optical action potential
signals. Since the light illumination on the cardiac tissue is not homogeneous,
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the relative motion of the cardiac tissue with respect to the light sources is
also an important factor which enhances motion artifacts.
3. Inhomogeneous dye concentration: Loading of voltage/calcium sensitive
dyes is not always homogeneous. When the heart contracts, these variations
in dye concentration also contribute to the signal distortion due to motion
artifacts.
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Fig. 2.6: Mechanical contraction of the cardiac tissue causes motion artifacts in
optical mapping experiments. A) Sources producing motion artifacts:
Loss of correspondence between camera pixel and the tissue due to the
relative motion between them, inhomogeneous illumination and spatial
(also temporal) dye concentration differences. B) Comparison of action
potential time series with and without motion for two different pixels (7
mm apart) from the left ventricular surface of a rabbit heart. Electrome-
chanical uncoupler Blebbistatin (5.6 µM) is used to suppress the motion.
The time series with motion are highly distorted due to motion artifacts.
C) Motion amplitude (see section 5.4 for computation details) from same
pixels used in panel B . Though motion amplitudes are identical in both
the pixels (difference in motion amplitude is roughly 1 pixel), the total
motion artifacts are different in these pixels as indicated by different signal
distortions in panel B (action potential with motion).
and the electrophysiological signals obtained from a contracting heart are
usually distorted with motion artifacts arising from all these sources.
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Figure 2.6 B shows the comparison of action potential time traces for two
different pixels (pixel 1 and pixel 2 which are 7 mm apart) from the left
ventricular surface of a rabbit heart with (upper row, motion) and without
(lower row, no motion) contraction. The upper rows of both pixels show
distortions of action potential signals due to motion artifacts resulting from
the contractile motion of the heart. The time series in the lower rows are the
action potential signals for the same pixels after inhibiting the contraction
using Blebbistatin. Figure 2.6 C shows the amplitude of contractile motion,
calculated as the displacement of the cardiac tissue (detailed description of
the calculation is in section 4.1) for the pixels used in panel B. As it is clear
from panel C, the locations of cardiac tissue corresponding to both these
pixels displace by similar amounts upon contraction, which results in an
identical motion amplitude (the difference in maximum amplitude of motion
is around 1 pixel).
Though the pixels displace by virtually identical amounts in panel C, the
motion artifacts based signal distortions shown in panel B (upper rows of
pixel 1 and 2) are significantly different. This indicates the presence of other
factors/sources contributing to the signal distortions such as inhomogeneous
lighting and heterogeneity in dye concentration across the heart as indicated
in panel A.
2.5.2 Excitation-contraction uncoupling
Motion artifact-free electrophysiological signals are of high demand while
using optical mapping technique. Motion artifacts emerging from contractile
motion have been suppressed pharmacologically using excitation-contraction
uncouplers in most of the optical mapping experiments. These uncouplers
uncouple the electrical excitation and mechanical contraction by suppress-
ing the mechanical activity of the cardiac tissue whereas, but they preserve
the electrical activity of the tissue. Hence these uncouplers enhance the
optical mapping signals by significantly reducing motion artifacts. Various
uncouplers such as diacetyl monoxime (DAM)[Liu+92], 2,3-butane-dione
monoxime (BDM)[Ket+04a; LLE12], Cytochalasin-D [Ket+04a], etc. were
used in optical mapping studies to minimize motion artifacts while imaging
action potential and calcium concentration from the cardiac tissue. Though
all these uncouplers are very effective in reducing the motion artifacts, they
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all have significant limitations. Among these, the most reliable and recent
uncoupler is Blebbistatin, which is considered as the electromechanical un-
coupler of the choice in most of the optical mapping experiments involving
Langendorff perfused hearts, isolated ventricles and atria and ventricular
myocytes after its first application in cardiac research [Fed+07]. Blebbistatin
inhibits the myofilament myosin and hence, suppresses the mechanical con-
traction of the hearts. Mechanical constraints were also used in some optical
mapping studies to diminish motion related artifacts [Man+98; Lau+98;
Che+00].
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Experimental methods
3
This chapter describes the optical mapping experimental techniques used to
image action potential wave activity of Langendorff perfused hearts. The
voltage sensitive fluorescent dye Di-4-ANEPPS is used to record optical mea-
surements of action potential wave propagation on the surface of isolated
rabbit hearts kept at physiological conditions. The chapter starts with an
introduction to ratiometric imaging used to enhance action potential signal
quality with optical methods by minimizing the adverse effects of several
quantities which are independent of action potential. Detailed analysis of
excitation and emission spectra of Di-4-ANEPPS and different ratiometric
imaging techniques are also described. Finally, the experimental setup includ-
ing all the important components used for action potential measurements is
introduced and a short overview of optical mapping data processing is given.
3.1 Ratiometry
A drawback of the conventional optical mapping method (Figure 2.5) is
that the fluorescence signal captured by the detector from a particular loca-
tion contains not only the information of electrophysiological parameters of
interest but also the local effective dye concentration and local excitation
light intensity. The effective dye concentration and excitation light intensity
are likely to vary spatially across the cardiac tissue. Additionally, there are
temporal variations of dye concentration due to photobleaching, washout
and compartmentalization [Bac+11]. These inhomogeneities in dye concen-
tration and excitation light intensity produce different fractional changes in
fluorescence (∆F) with respect to the electrophysiological parameter under
study, in different regions of the heart. Hence, the nonuniformity in dye
concentration and light intensity not only make the direct comparison of elec-
trophysiological parameters within the heart difficult, but also contributes to
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total motion artifacts as discussed in section 2.5.1 when optical mapping is
performed with contracting hearts.
The ratiometric optical mapping technique minimizes the effects of inho-
mogeneous dye loading and variation in light intensities by using common
mode rejection technique [Kni+00; Bac+11]. Ratiometry uses two bands of
wavelengths for excitation or emission unlike conventional optical mapping,
where single excitation and emission bands are used. As the name indicates,
ratiometry is a measurement involving the ratio of two fluorescence signals,
which have different fractional changes of fluorescence (∆F) with respect to
the electrophysiological parameters of interest, but have common artifacts
from all other sources (dye loading and lighting inhomogeneities). Hence tak-
ing the ratio between these two fluorescence signals cancels out the artifacts
common to both the signals and improves the signal quality.
Two commonly used ratiometric techniques are emission and excitation
ratiometry. Emission ratiometry uses single excitation wavelength and two
emission wavelengths are recorded with two detectors, which are aligned to
image the same location of the cardiac tissue (corresponding pixels of both
detectors image the same tissue). Emission ratiometry was used to reduce
motion artifacts in rabbit hearts with two photomultiplier tubes [Kni+00]
to collect the fluorescent emission. Though emission ratiometry is a useful
tool in obtaining high resolution electrophysiological signals with minimal
motion artifacts (artifacts due to illumination and dye concentration), the
complexity in aligning the detectors and the cost of the detectors are the
main drawbacks of this technique.
Excitation ratiometry uses two excitation wavelengths and a single emission
band to record the fluorescence signals. The excitation wavelengths are
usually switched with high frequency and the fluorescence signals acquired
with a single emission band are used for ratiometric measurement. Excitation
ratiometry is simpler than emission ratiometry since there is no need to
align two detectors carefully to perform ratiometric measurements on elec-
trophysiological signals. But the excitation light needs to be switched with
high frequency to record the fast variations in signals with both excitation
wavelengths. Nowadays, this is achieved through high power LEDs, which
can be switched at higher speeds compared to the traditional light sources.
Excitation ratiometry was used to measure cardiac action potentials with
reduced motion artifacts [Bac+11]. It was also combined with marker based
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motion tracking to record action potential signals from contracting hearts
[Zha+16].
To minimize the dye loading and the illumination (partially) artifacts from
the optical action potential signals, excitation ratiometry is preferred over
emission ratiometry in this thesis because of two main reasons. First, as
mentioned before, due to the complexity in the alignment of two cameras
to image same location of the cardiac tissue. Second due to the ease of
availability of components for excitation ratiometry. For example, an LED
switching box (same as shown in Figure 2.5) and optical components (optical
filters, LEDs and lenses) for one excitation wavelength were already available
in the lab from previous experiments (multi-parametric imaging).
3.1.1 Excitation ratiometry
Excitation ratiometry utilizes the ratiometric properties of the voltage sen-
sitive fluorescent dye Di-4-ANEPPS. This dye undergoes voltage dependent
spectral shifts in the absorption and emission spectra as shown in Figure 3.1
during electrical excitation of the cardiac tissue with the action potential.
As shown in Figure 3.1 A, the absorption spectrum of Di-4-ANEPPS show
spectral shifts towards lower wavelengths for all the excitation wavelengths
within the range 360 nm-575 nm. As a result, the excitation wavelengths
above the excitation isosbestic point (wavelength at which no change in
absorption between resting and depolarization ≈ 480 nm) show opposite
polarities in voltage dependent spectral change compared to the wavelengths
below the isosbestic point. These voltage dependent excitation shifts pro-
duce voltage dependent shifts in emission spectra as shown in Figure 3.1
B. The black circles show the emission isosbestic points, where the resting
and depolarized cardiac tissue produce no change in fluorescence emission.
The emission spectra for blue and cyan excitation undergo action potential
dependent fractional change in fluorescence ∆F in opposite directions. ∆F
is positive for blue excitation whereas, ∆F is negative with cyan excitation
wavelength.
Since the cyan and green excitation light has comparable wavelengths and
the fluorescent emission for green excitation shows negative value of ∆F
similar to cyan excitation wavelength, it is reasonable to perform ratiometric




Fig. 3.1: Action potential dependent absorption and emission spectra of Di-4-
ANEPPS. A) Voltage dependent shift in excitation spectra from resting
state (solid) to depolarized state (dashed) of the cardiac tissue with an
action potential upstroke. Black circle represents the isosbestic wavelength
at which no change in excitation between resting and depolarized states.
B) Voltage dependent shift in emission spectra for blue (450 nm) and
cyan (505 nm) excitation wavelengths. Blue and cyan excitation result
in two resting emission spectra (solid gray and black lines, respectively).
The emission spectra undergo a voltage dependent shift and amplitude
modulation resulting from the action potential-dependent excitation shift
(dashed lines). The black circles show the emission isosbestic points at
which there is no change in fluorescent emission between resting and de-
polarized states. Note that, blue and cyan excitation wavelengths produce
fractional change in fluorescence with opposite polarities. Figure reused
with permission from [Bac+11].
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exists no signal cross talk. Hence, the excitation ratiometric measurements in
this thesis were performed by utilizing blue and green excitation wavelengths.
The action potential modulated fluorescent emissions were recorded on a
single EMCCD camera with the help of a bandpass emission filter (590 nm
±55 nm).
Though blue and green elicited action potentials contain ∆F of different
magnitudes and polarities, the effective dye concentration on the cardiac
tissue is the same for both wavelengths. Also, it is possible to make illumina-
tion intensity nearly homogeneous by adjusting blue and green excitation
light during the experiment. Hence, the ratio of blue and green elicited
action potential signals is less susceptible to variation in dye concentration
and illumination intensity across the heart tissue. Additionally, the opposing
nature of ∆F polarity amplifies the action potential sensitivity while taking
the ratio between these two signals.
3.2 Experimental setup and description
Figure 3.2 shows the schematic of the ratiometric optical mapping (excitation
ratiometry) experiment used to record action potential signals from rabbit
hearts kept at physiological conditions. The excitation ratiometric imaging
system uses two wavelengths of excitation (blue and green) and collects the
fluorescent emission on a single detector. Blue and green excitation light
were provided by two sets of high-power light-emitting diodes (3 blue LEDs:
460 nm center wavelength, model LZ4-40B208; 3 green LEDs: 523nm center
wavelength, model LZ4-40G108, both by LED Engin Inc., USA). The blue and
green excitation light was further filtered by two sets of narrow bandpass
filters mounted in front of the light-emitting diodes (blue: 460 nm ± 5 nm,
Thorlabs, USA; green: 540 nm ±12.5 nm, Chroma Technology Corp., USA).
The excitation light was also collimated with plano convex lenses (LA1951-A,
Thorlabs, USA), which were placed between the LEDs and the excitation
filters. The action potential modulated fluorescent light from the cardiac
tissue for blue and green excitation are captured with an EMCCD camera
(Evolve 128, Photometrics 128x128 pixels, 16-bit dynamic range) equipped
with a lens (0.95/25 mm, Navitar) and a bandpass emission filter (590 nm
± 55 nm, Omega Optical). An LED switching box (from I. Uzelac and F.
Fenton, Georgia Tech) switches the light between blue and green with a





























Fig. 3.2: Experimental setup showing ratiometric optical mapping. A) Langendorff
perfused contracting rabbit heart is loaded with voltage sensitive dye Di-
4-ANEPPS. Emitted fluorescent light from the cardiac tissue, modulated
by the action potential for blue and green excitation is captured by an
EMCCD camera equipped with a bandpass emission filter. B) Separating
the camera frames (500 fps) into odd and even frames yields the action
potential for blue and green excitation (250 fps in each channel). C) Dual
wavelength excitation used for ratiometric imaging. A light switching
led driver box is used to switch the excitation light between blue and
green(light pulses are of 1.85 ms duration) with each camera frame. D)
A bandpass emission filter (590 nm ±55 nm) is used to capture action
potential corresponding to blue and green excitation with a single camera.
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high frequency (500 Hz) and this switching is synchronized with the camera
(records at 500 frames per second) using a camera trigger output from the
LED switching box.
3.3 Optical mapping data processing
Multiple pre-processing steps have been performed on optical mapping data
to precisely calculate electrophysiological parameters of interest from con-
tracting and Blebbistatin-uncoupled hearts. The optical mapping setup shown
in Figure 3.2 records action potential signals corresponding to blue and
green excitation wavelengths interlaced in time. The first step of data pre-
processing is the separation of these interlaced time traces into action poten-
tials corresponding to blue and green excitation light. The camera frames
containing action potential modulated fluorescent intensities (F) for blue and
green excitation light are separated into odd and even video frames such that
all odd frames represent action potential due to blue excitation, whereas all
even frames correspond to action potential due to green excitation light. The
Figure 3.3 illustrates the splitting of time interlaced optical action potentials
(contain action potentials due to both blue and green excitation light; 2000
frames) into action potentials corresponding to blue and green excitation
light (1000 frames each). The time traces represent optical action potentials
from a single pixel corresponding to a portion of left ventricular tissue. Panel
A shows the time interlaced action potentials from a beating heart (raw
signal) of 4 seconds duration with 500 fps. Panel B illustrates the separation
of time traces shown in panel A into action potentials corresponding to blue
and green excitation light (each of 4 seconds duration with 250 fps). Panel C
shows the time interlaced action potentials in Blebbistatin-uncoupled condi-
tion. Panel D illustrates the separation of time interlaced action potentials
shown in panel C into action potentials of blue and green excitation light.
Action potential modulated fluorescent video sequences obtained with blue
and green excitation light are stored as normalized videos by normalizing
the fluorescent intensity values of the video sequences using the minimum
and maximum intensity values of the entire fluorescent video fv as
Inorm(x, y, t) = (fv(x, y, t)−min(fv))/(max(fv)−min(fv)) (3.1)
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A C
B D
AP from beating heart AP with Blebbistatin
Fig. 3.3: Exemplary time traces (relative fluorescent intensity F as a function of
time or frames) from single pixel (from left ventricle) illustrating optical
mapping data pre-processing. A) Time interlaced optical action potentials
due to blue and green excitation light in contracting condition. B) Separa-
tion of time traces shown in panel A into action potentials corresponding
to blue and green excitation. C) Time interlaced optical action potentials
in Blebbistatin-uncoupled condition. D) Separation of time series shown in
panel C into action potentials corresponding to blue and green excitation
light.
The normalized fluorescent videos are used for further data processing.
Numerical motion tracking techniques (see section 4.1) are used to track the
motion of the heart from normalized fluorescent videos of blue and green
excitation light, separately. The ratio between motion tracked fluorescent
videos of blue and green excitation light are computed and stored for ratio-
metric measurements. Similarly, ratio video sequences are computed and
stored from action potentials corresponding to blue and green excitation in
Blebbistatin-uncoupled condition as well.
3.3.1 Spatio-temporal smoothing
For the precise measurement of electrophysiological parameters such as ac-
tion potential duration, ratio video images are smoothed spatio-temporally. It
means the intensity value of each pixel is averaged spatially using surround-
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ing pixels and temporally using nearby frames according to size of the kernel.
The data processing mentioned in this thesis used spatio-tempral filtering






Fig. 3.4: Concept of spatio-temporal smoothing with a kernel size of 3× 3× 3 for
two different pixels P1 and P2. The intensity value of P1 (or P2) in the
smoothed video is calculated as the mean value of fluorescent intensities
from the neighbouring 3 × 3 pixels (green) including P1 (or P2) from
frames t, t-1 and t+1.
Figure 3.4 illustrates the idea of spatio-temporal smoothing for two differ-
ent pixels P1 and P2. To compute the smoothed intensity value corresponding
to the pixel P1 at frame t, the intensity values of 3× 3 neighbouring pixels
with P1 as the center is constructed. Similarly corresponding 3× 3 pixels are
identified in frames t-1 and t+1. The intensity value of P1 in the smoothed
video is calculated as the mean value of intensities from all these 27 pixels.
The complete smoothed video is produced by repeating the method for all
pixels and for all the video frames. For measurement of electrophysiological
parameters such as action potential duration and frequency of ventricular
fibrillation, spatio-temporal smoothing with a kernel size of 3× 3× 3 is used
consistently in this thesis. This filtering was used to measure the desired
quantities from all pixels in the video images (signal to noise ratio gets worse
at some pixels). However, for visualization of the quantities spatial averaging
of 3× 3 pixels is often used.
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3.3.2 Sliding window normalization
The automatic calculation of action potential durations (see section 5.1.1)
is much easier when all the action potentials of a particular pixel (after














Fig. 3.5: Exemplary time traces illustrating the effect of smoothing and normaliza-
tion of optical action potentials. The smoothed optical action potential
time traces (smoothed; black) are obtained by spatio-temporal averaging
(3× 3× 3) of single pixel time traces (raw; red). A sliding window normal-
ization is used to normalize each action potential (window normalization;
magenta) in the interval [0 1]. The time traces are obtained from the left
ventricular surface of a rabbit heart during electrical pacing with CL=350
ms. The contraction of the heart was inhibited by Blebbistatin.
are extracted for each pixel and all the action potentials are normalized in the
range [0 1] using a sliding window normalization. A window of proper size is
moved along the time axis and the minimum and maximum values of action
potentials in every time window are calculated. The action potentials are
normalized within that window using the observed minimum and maximum
values. Each action potential is normalized by choosing a window size equal
to the number of frames corresponding to a single action potential. The
Matlab commands movmin and movmax are used to calculate minimum and
maximum values of action potential within each time window.
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Figure 3.5 shows the effects of spatio-temporal smoothing and sliding
window normalization on single pixel optical action potential time traces. The
time traces are calculated from ratio video images in Blebbistain-uncoupled
condition. The spatio-temporal smoothing of single pixel time traces (raw;
red) resulted in smoothed action potentials (smoothed; black) with less noise
in it. The smoothed action potential traces are normalized with a sliding
window normalization (window normalization; magenta) with a proper
window size (≈ number of frames corresponding to one action potential,
w=100 here).





As discussed in section 2.5.1, the fluorescence signal distortion due to mo-
tion artifacts is a limitation in optical mapping experiments. These motion
artifacts of electrophysiological signals are usually removed as described in
section 2.5.2 either by using excitation-contraction uncouplers or by mechan-
ically restricting the heart. The electromechanical uncouplers are effectively
reducing motion artifacts in action potential or calcium concentration signals.
However, some of these uncouplers were shown to have effect on cardiac
electrophysiology. Additionally, uncoupling of electrical activity from cardiac
mechanics is not physiological since there is no mechanical contraction in-
volved. On the other hand, numerical motion tracking was performed to
record action potential and mechanical contraction in Langendorff perfused
contracting hearts by attaching polyethylene markers on the left ventricular
epicardium [Bou+11; Zha+16]. Though these studies were able to image
action potential wave propagation from beating hearts without using pharma-
cological uncoupling, the presence of markers reduces the spatial resolution
of obtained fluorescence signals. And, recently, marker-free motion tracking
was used to numerically track and compensate the motion of contracting
hearts to measure action potential wave phenomena propagating across the
contracting heart surface [CL18]. This chapter describes the marker-free
numerical motion tracking technique used to measure action potential signals
from optical mapping studies involving beating hearts.
4.1 Marker-free motion tracking
The basic concept behind motion tracking is to find geometric transforma-
tions that align (or register) multiple images with a reference image. In order
to obtain action potential signals from a contracting heart (with minimum
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motion artifacts), the contractile motion of the heart has to be tracked for all
camera frames with respect to a reference frame. This section describes the
motion tracking algorithm used to track and register video sequences of a
contracting heart. The motion tracking algorithm is based on the work by
Periaswamy et al. [PF03; KP03].
Let f(x, y, t) and f(x̂, ŷ, t−1) represent test and reference images respectively.
By assuming brightness constancy (difference in brightness between these
images is only due to motion and not due to any brightness variations) and a
local affine model for transformation between the images results in
f(x, y, t) = f(a1x+ a2y + a5, a3x+ a4y + a6, t− 1) (4.1)













Now, the goal is to compute the six parameters,
~a =
(
a1 a2 a3 a4 a5 a6
)T
(4.2)
corresponding to the geometrical transformation between test and refer-





[f(x, y, t)− f(a1x+ a2y + a5, a3x+ a4y + a6, t− 1)]2 (4.3)
such that test image aligns with the reference image when the error is at
minimum value. Ω in (4.3) represents a small spatial neighborhood.
Since the functional form of f on the parameters (ai) are unknown, the error
function in (4.3) cannot be minimized analytically. Hence, the minimization
is simplified by approximating the error function using a first-order truncated
Taylor series expansion:







f(x, y, t) + (a1x+ a2y + a5 − x)fx(x, y, t)+
(a3x+ a4y + a6 − y)fy(x, y, t)− ft(x, y, t)
])2
(4.4)
where fx(.), fy(.) are spatial derivatives of f(.) and ft(.) is the temporal





ft(x, y, t)− (a1x+ a2y + a5 − x)fx(x, y, t)−
(a3x+ a4y + a6 − y)fy(x, y, t)
]2
(4.5)





k − ~c T~a
)2
(4.6)
where the vector ~c and scalar k are defined as:
k = ft + xfx + yfy (4.7)
~c = (xfx yfx xfy yfy fx fy)T ; (4.8)
Now, the error function in (4.6) can be minimized analytically by differenti-
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(4.9)
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This solution assumes that the 6 x 6 matrix
(∑




can usually be guaranteed by integrating over a large enough spatial region
Ω with sufficient image content.
The algorithm discussed above uses brightness constancy assumption.
However this assumption fails when the fluorescent intensity recorded on
the camera changes due cardiac action potentials. For example, an action
potential upstroke results in 4% fractional change in fluorescent intensity
(with Di-4-ANEPPS) within 8-12 ms (2-3 camera frames) duration.
Hence, to account for intensity variations, an explicit change of local
contrast and brightness is incorporated into (4.11) as
a7f(x, y, t) + a8 = f(a1x+ a2y + a5, a3x+ a4y + a6, t− 1) (4.11)
where a7 and a8 are spatially varying parameters that incorporate changes
in contrast and brightness, respectively. The error function in this case is









ki = ft − f + xfx + yfy (4.13)
~ci = (xfx yfx xfy yfy fx fy − f − 1)T (4.14)










(4.15) is used to compute local affine and contrast/brightness parameters





are assumed to be constant in this spatial neighborhood. Choosing
the size of Ω is tricky due to to the fact that selecting larger area makes
it more likely that
∑
x,y ∈Ω ~ci ~ci
T will be invertible. On the other hand, a
smaller spatial neighborhood makes it more likely that brightness constancy
assumption will hold. The balancing of these two issues is important for
accurate calculation of model parameters. Hence, to avoid the difficulty in
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balancing these issues, the constancy assumption of model parameters are
replaced by smoothness constraint assumption in which the local affine and
contrast/brightness parameters vary smoothly across space.
The smoothness constraint is incorporated into the algorithm by aug-
menting the error function shown in equation (4.12) with an error function
corresponding to smoothness constraint Es(~ai) as
Ebs(~ai) = Eb(~ai) + Es(~ai) (4.16)
where Eb(~ai) is same as equation (4.12) without summation.
Eb(~ai) =
[


















where λi is a positive constant that controls the relative weight given to
the smoothness constraint on parameter ai. As before, the error function is











= 2L (am − ~ai) (4.20)
Where L is an 8× 8 diagonal matrix with diagonal elements λi and zero
off diagonal elements. am is the component-wise average of ~ai over a spatial
neighborhood.
An iterative relation is obtained for the calculation of model parameters
by setting the sum of above two differentials to zero. The parameters ai are















On each iteration, the geometric transformation estimated from equation
(4.21) is applied to the test image and a new transformation is estimated
between the reference image and the newly warped test image. Additionally,
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to deal with larger motions, a course to fine scheme is included in the
algorithm. Initially, the geometric transformation is estimated at the coarsest
level using a Gaussian pyramid for both test and reference images. The
geometric transformation estimated in the coarsest level is used to warp
the test image in the next level of the pyramid. A new estimate of the
transformation is computed at this level, and the process is repeated at each
level of the pyramid. The transformations at each level of the pyramid are
accumulated yielding a single final geometric transformation between the
test and reference images.
Figure 4.1 shows an example of motion tracking on a fluorescent video
image of a contracting heart obtained with optical mapping experiment.
Panel A shows the variation of the amplitude of displacements across the



















Fig. 4.1: Example of motion tracking showing amplitude and direction of tissue
displacement calculated from the action potential video images obtained
with optical mapping. The displacement vectors were obtained between
two video images which were 300 ms apart in time. A) Magnitude of
tissue displacement in pixels. Bottom left image represents raw test image
(128 × 128 pixels, physical size of 30mm × 20mm). B) Displacement
vectors illustrating the direction of tissue movement upon contraction
from two different areas A1 and A2 of the heart. Area A1 shows uniform
motion of the cardiac tissue whereas, the area including the boundary of
the heart A2 shows non-uniform distribution of the displacement vectors,
indicating a limitation of the motion tracking algorithm at the boundary.
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(A1 and A2) on the left ventricular surface. The displacement vectors from
area A1 illustrate uniform motion of the cardiac tissue. But the displacement
vectors from area A2 show non-uniform motion of the heart tissue due to the
limitation of motion tracking algorithm in calculating the model parameters
at the boundaries of the heart.
4.1.1 Motion compensation
Motion compensated videos were obtained from the original raw videos
(moving) by using the displacement vectors calculated with the motion
tracking algorithm. Each video image of the original video sequence was
Reference image Test image Difference image
Raw





Fig. 4.2: Comparison of fluorescent images of a beating rabbit heart from an optical
mapping experiment without motion tracking (upper row) and with mo-
tion tracking and compensation (lower row). The difference image on the
upper row shows substantial pixel intensity differences between the test
(at 300 ms) and reference image (at 0 ms) due to the relative motion of the
contracting heart with respect to the camera. The difference image on the
lower row shows comparatively negligible pixel intensity difference when
the motion of the test image is tracked and compensated with respect
to the reference image. The mean square error (mse) between test and
reference image before tracking was 0.0015 and after motion tracking the
error reduced to 0.0006.
geometrically transformed using the tracked displacements to match the
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image in the reference frame. All registered video images were stacked
to produce a final motion compensated video and it was stored separately
for further analysis. An example of numerical motion tracking and motion
compensation of a rabbit heart video image is shown in Figure 4.2. The
upper row shows the difference between a test and reference image of a
contracting heart before applying numerical motion tracking and motion
compensation. The temporal difference between test and reference images
is 300 ms (75 frames). The difference image (raw) is characterized by
substantial pixel intensity variation due to the displacement of the test
image upon contraction with respect to the reference image. On the other
hand, motion compensated difference image on the lower row shows less
variation in pixel intensity between the motion compensated test image and
the reference image, indicating proper registration between the images with
the application of motion tracking and motion compensation.
4.2 Action potential wave propagation in
motion tracked hearts
Optical mapping experiments were conducted on contracting rabbit hearts
with dual excitation wavelengths as shown in Figure 3.2 in order to do
ratiometric action potential measurements. The heart was stained with
voltage sensitive ratiometric dye Di-4-ANEPPS and the fluorescence signals
corresponding to blue and green excitation light were collected with a single
bandpass emission filter as shown in Figure 3.1. The optical mapping data
captured with blue and green excitations were separated and stored as
normalized videos with intensity values I ∈ [0 1] using equation (3.1).
Motion tracking was applied on both blue and green elicited fluorescence
video images separately with the first frame of each video sequence serving
as the reference. Motion tracked blue and green action potential videos were
compensated as mentioned in section 4.1.1.
An example of action potential wave propagation from a contracting heart
before and after motion tracking for blue and green excitation wavelengths
is shown in Figure 4.3. The action potential dependent fractional change in
fluorescent signal ∆F for blue excitation is less in magnitude (with positive
sign), which makes it difficult to visualize the intensity variation in video
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Fig. 4.3: Motion artifacts affecting action potential wave propagation. Comparison
of wave propagation in contracting heart before (raw) and after (tracked)
motion tracking for blue and green excitation wavelengths. A) Action
potential wave propagation on a ventricular surface with blue excita-
tion. Action potential before motion tracking (raw blue) shows significant
motion artifacts(≈ 2 pixels representing 0.4 mm of cardiac tissue) as com-
pared to motion tracked case (tracked blue). B) Action potential wave
propagation with green excitation light. Dark areas represent depolar-
ized tissue and bright areas correspond to repolarized tissue. All optical
mapping images show normalized pixel intensities over time.
images. The ∆F for green excitation is negative and hence the action potential
wave propagation is characterized by decreasing intensity in the images
from t=0 ms to t=24 ms. The action potential wave propagation before
motion tracking (raw blue and raw green) for blue and green excitation
shows substantial distortions in action potential wave propagation due to
the superposition of contractile motion with the action potential. The action
potential wave propagation are affected by motion artifacts due to relative
motion between the cardiac tissue and the detector, inhomogeneous dye
concentration and illumination inhomogeneities. The action potential wave
propagation with motion tracking (tracked blue and tracked green) show
comparatively less motion artifacts due to the removal of relative motion
artifacts present in the raw video images. However, dye concentration and
illumination artifacts are still present in the video images as indicated by the
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non-uniform intensity variation across the heart in motion tracked images
with an action potential depolarization (see Figure 4.3 B at 24 ms).
4.3 Marker-free motion tracking and excitation
ratiometry
As the motion tracking alone is not enough to produce artifacts-free action
potentials, a combination of excitation ratiometry with marker-free motion
tracking is employed to enhance action potential signal quality by removing
the residual artifacts present in the signal. As mentioned in the previous
section, motion tracked videos were obtained by tracking the motion of the
cardiac tissue for blue and green excitation light separately. The motion
tracked videos corresponding to action potentials for blue and green exci-
tation are used to produce ratiometric video images. The ratio between
these action potentials is calculated by dividing the action potentials for
blue excitation light (positive ∆F) with action potentials for green excitation
(negative ∆F). This convention is used in all ratio measurements throughout
the thesis in order to produce an upward action potential depolarization (see
Figure 4.4 A, ratio).
Figure 4.4 shows the effect of combined motion tracking and ratiometric
measurements on action potential time series obtained during electrical pac-
ing at a cycle length CL=350 ms. Figure 4.4 A shows the variation of action
potential time traces in contracting (raw) and motion tracked conditions. The
video images were normalized with the maximum and minimum intensity
values from the entire video sequence as given in equation (3.1) before track-
ing the motion. The colors blue, green and black represent action potential
time traces with blue excitation, green excitation and ratio (blue/green),
respectively. Figure 4.4 B shows all the time traces shown in Figure 4.4 A
by normalizing them in the interval [0 1] with a sliding window (by using
the maximum and minimum value of action potential inside the window).
The size of the sliding window is taken as the cycle length to make sure that
there exists at least one action potential in each window. Green excitation
results in downward action potential depolarization due to the reduction in
fluorescent intensity with action potential depolarization (negative ∆F) as
shown in Figure 3.1. Conversely, blue excitation produces upward action
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Fig. 4.4: Effects of motion tracking and ratiometry on optical action potential
traces from a contracting heart at a pacing cycle length of CL= 350 ms.
Comparison of optical action potential time traces from a rabbit heart
before and after motion tracking A) Action potential from a contracting
heart before (raw) and after motion tracking (motion tracked). Ib and
Ig represent the fluorescent intensity corresponding to blue and green
excitation and Iratio is the ratio between optical action potentials obtained
with blue and green excitation light. The optical action potential signal
corresponds to blue excitation light produces a very small fractional change
(∆F/F<1%) of fluorescence with cardiac depolarization as compared
to green light excitation (∆F/F ≈ 3%). Neither ratiometry nor motion
tracking alone can remove all the motion artifacts but the combination
of both these techniques reduces motion artifacts to a great extend. B)
Action potential time traces obtained with sliding window normalization
of signals shown in panel A.
potential depolarization due to the increase in fluorescent intensity with
action potential depolarization. However, there is only a small fraction of
action potential signal (∆F/F<1%) with blue excitation light. The motion
tracked data corresponding to blue excitation shows mostly residual artifacts
due to the dye concentration and illumination changes which exist even
after motion tracking and compensation. On the other hand, green elicited
action potential shows comparatively higher fluorescent change (∆F/F ≈3%),
which amplifies the action potential in the ratio signal and produces higher
fractional change in fluorescence (∆F/F ≈4%). The motion tracked action
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potential with green excitation light (Ig, motion tracked) shows significant
improvement in signal quality compared to the raw signal (Ig, raw) as visible
by the change in shape of the action potential during repolarization. How-
ever, the baseline of the action potential at the diastolic interval is slightly
distorted due to motion artifacts originating from nonuniform dye concen-
tration and illumination changes. Motion artifacts arising from nonuniform
dye concentration across the heart tissue are common in action potentials
corresponding to blue and green excitation light.








Fig. 4.5: Variation of fluorescent intensity across the heart tissue with blue exci-
tation, green excitation and ratio. A) Normalized fluorescent intensity
(pixel intensities were divided by the maximum intensity) calculated from
an exemplary video images (snapshots) corresponding to blue excitation
(upper row), green excitation (middle row) and ratio (lower row) as a
histogram. B) The snapshots of the heart used to compute the histogram.
The images from top to bottom represent normalized fluorescent intensity
across the heart tissue for blue excitation, green excitation and ratio. The
ratio image shows homogeneous intensity across the heart tissue.
However, motion artifacts originating from inhomogeneous illumination of
the tissue are not common in these action potentials since the light intensity
variations across the heart tissue with blue and green excitation light are not
same. Hence, special care was taken during the experiment to arrange these
light sources such that the ratio image shows nearly homogeneous intensity
across the tissue. This was done by adjusting the blue and green light sources
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by looking at the ratio image. Figure 4.5 illustrates fluorescent intensity
variations across heart tissue with blue excitation, green excitation and ratio.
The ratio image shows homogeneous intensity distribution across the cardiac
tissue as compared to fluorescent video images of blue and green excitation.
Now, the illumination related artifacts and dye concentration artifacts are
common in action potential signals produced with blue and green excitation
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Fig. 4.6: Effect of combined motion tracking and excitation ratiometry on action
potential wave propagation in contracting rabbit hearts. Motion tracked
action potentials corresponding to blue (tracked blue) and green (tracked
green) action potentials showing illumination and dye concentration ar-
tifacts. Ratiometric measurements illustrating reduced motion artifacts
compared to motion tracked action potentials of blue and green excitation
light. All optical mapping images show normalized pixel intensities over
time. Bright areas corresponding to depolarized tissue in ratio whereas,
dark areas corresponding to depolarized tissue in tracked green.
blue and green excitation in motion tracked condition (Iratio, motion tracked)
results in action potential time traces with significant reduction in motion
artifacts. It is interesting to note that even without motion tracking, the
ratio between raw action potentials produce time traces, which at least have
similar morphology of motion tracked action potential. Nevertheless, motion
tracking or ratiometry alone is not sufficient to remove all the motion related
artifacts.
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The effect of combined motion tracking and ratiometry on action potential
wave propagation (produced during electrical stimulation, CL=350 ms) is
shown in Figure 4.6. Motion tracked action potentials with blue (tracked
blue) and green (tracked green) excitation light contain illumination and dye
concentration artifacts. Ratiometry removes these artifacts significantly (but
illumination artifacts are only partially removed). The wave propagation
across the heart becomes more homogeneous and consists of less motion
artifacts compared to motion tracked action potentials of blue and green
excitation light. As discussed in section 4.3, blue excitation produces smaller
∆F/F value.
4.4 Comparison of action potential time traces
between contracting and Blebbistatin-
uncoupled hearts
The action potential time traces obtained with combined motion tracking
and excitation ratiometry are compared with action potentials obtained
from Blebbistatin-uncoupled hearts, where the mechanical contraction is
uncoupled pharmacologically from electrical activity. Figure 4.7 shows the
comparison of action potentials from a contracting heart with motion tracking
(motion tracked) and with Blebbistatin administration (Blebbistatin).
Colors blue, green and black represent action potentials with blue exci-
tation, green excitation and ratio (blue/green), respectively. Figure 4.7 A
shows this comparison in which action potential with motion tracking and
ratiometry (Iratio, motion tracked) shows similarity in morphology with that
of Blebbistatin administrated heart (Iratio, Blebbistatin). Figure 4.7 B shows
the same time traces of Figure 4.7 A with sliding window normalization.
The motion compensated action potentials (action potentials obtained with
motion tracking and ratiometry) show significant reduction in motion related
artifacts, which encourage the use of motion tracking and ratiometric tech-
niques to measure electrophysiological parameters in a precise manner. And
these techniques allow the simultaneous measurement of action potential and
contractility of the hearts without using any pharmacological suppression.





Fig. 4.7: Comparison of optical action potentials in motion tracked and Blebbistatin-
uncoupled rabbit hearts at a pacing cycle length of CL= 350 ms. A) Action
potential time traces with blue excitation (blue), green excitation (green)
and ratio (black). The time traces obtained from the left ventricular surface
by spatially averaging 3× 3 pixels. The blue and green video images were
normalized before motion tracking by using the maximum and minimum
intensity value found in the entire video sequence. B) Time traces of panel
A with sliding window normalization. Combined motion tracking and
ratiometry produces action potential time series with negligible residual
artifacts, which has similar morphology of that of action potential with
Blebbistatin.











Restitution properties of the heart in a contracting condition are not well
studied and high resolution optical mapping studies of cardiac restitution
involving contraction without using markers are still missing due to the
motion artifacts created by the mechanical contraction of the heart. This
chapter mainly focuses on the precise measurement of action potential dura-
tion (APD) and cardiac restitution properties of a contracting heart by using
combined marker-free motion tracking and ratiometric imaging techniques.
Also, a systematic comparison of APDs and restitution properties of the heart
in contracting and non-contracting (contraction inhibited by Blebbistatin)
conditions is described in detail.
5.1 APD and electrical restitution
Electrical restitution is the dependence of heart’s electrophysiological prop-
erties such as action potential duration (APD) or conduction velocity (CV)
on pacing cycle length (CL). Though restitution properties of both APD and
CV contain important information of the dynamics of the heart, this thesis
is only focusing on APD restitution, which is the change in APD with CL (or
change in APD with diastolic interval (DI)). APD is the duration of action
potential (AP), usually represented with a number as a subscript indicating
the percentage of repolarization of the cardiac tissue. For example, APD50
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is the duration of AP at 50% repolarization, APD70 is the duration of AP
corresponding to 70% repolarization and so on. CL is the time period of
electrical stimulus used to pace (stimulate) the heart. Lowering the values of
CL increases the pacing frequency (fp) since they follow a reciprocal relation.
Diastolic interval (DI) is the relaxation time of the heart during diastole. The
relationship between APD, DI and CL is shown in Figure 5.1.
While pacing the heart with electrical pulses of appropriate frequency (or
pacing cycle length), the heart tries to capture the frequency and as a result
if capture occurs, the heart beats at that particular frequency. This causes
APD and DI to vary with CL by satisfying the following equation





















Fig. 5.1: Variation of action potential duration (APD) and diastolic interval (DI)
with pacing cycle length (CL). Representative time series for two pacing
cycle lengths (CL=350 ms and CL=250 ms) showing APD and DI at
50% (APD50 and DI50) and 70% (APD70 and DI70) repolarization. Time
series obtained from the left ventricular surface of a rabbit heart after the
administration of Blebbistatin.
Figure 5.1 shows that both APD and DI shorten as we decrease the pacing
cycle length from CL=350 ms to CL=250 ms (or increase the pacing frequency
from fp=2.86 Hz to fp=4 Hz). As we increase the frequency further, if the
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heart captures, the APD and DI go on decreasing until ventricular arrhythmia
is reached. It can also happen that cardiac tissue is unable to capture the
pacing when the frequency is very high (for rabbit hearts fp>6 Hz). Hence
to make sure that the heart captures for all the pacing frequencies to be
investigated, the amplitude of the pacing pulses were kept at the maximum
value in all the experiments.
There exist two standard protocols to measure the electrical restitution
properties of the hearts, namely standard restitution and dynamic restitution
[Kol+98; Osa12]. In standard restitution (S1-S2 restitution) protocol, the
heart is paced with a train (10 or 20) of regular pulses (S1) at a constant
pacing cycle length (usually, the shortest cycle length at which there are no
beat to beat variations in APDs). Once steady state in APD and DI is reached,
an extrastimulus (S2) is delivered to the tissue and the response of APD
for S2 stimulus is recorded. This protocol is repeated with a progressively
reduced S1-S2 coupling interval and the pacing is stopped once effective
refractory period with no ventricular capture is reached [Raw16]. The APD
for each S2 values is calculated and the restitution curve is plotted as either
APD over S1-S2 or APD over preceding DI.
In dynamic restitution protocol, the cardiac tissue is paced with regular
S1 pulses (usually 30 or 50) of constant cycle length. The cycle length (the
S1-S1 interval) is progressively shortened until the heart fails to capture the
pacing. The APD for each cycle length is calculated and the restitution curve
is plotted as either APD over CL or APD over preceding DI.
Effects of these restitution protocols were well studied in different ani-
mal species using standard electrode measurement of monophasic action
potentials. Since the objective of this thesis is not to compare different resti-
tution protocols, the remaining part of the thesis will only focus on dynamic
restitution.
5.1.1 Dynamic restitution in optical mapping
In order to assess the dynamic restitution during an optical mapping experi-
ment in our lab, the heart was paced with a train of 50 biphasic electrical
pulses of constant cycle length using a local pacing electrode (FHC Inc.,
USA) placed usually on the right ventricle. The pacing was started with a
cycle length of CL=500 ms and the cycle length was progressively shortened
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until CL=100 ms. The cycle length was decremented in steps of 50 ms until
CL=350 ms. After that, the cycle length was decreased in the interval of 20
ms from CL=320 ms to CL=200 ms. The cycle length was further reduced
in 5 ms intervals until CL=100 ms. The pacing was interrupted if the heart
failed to capture the stimulus or if ventricular fibrillation was induced. After
the restitution protocol was finished, APDs were calculated using custom
developed MATLAB programs.
Measurement of action potential duration
In order to measure APD, the optical mapping data was first spatio-temporally
filtered as explained in section 3.3.1 with a window size of 3 × 3× 3. The
filtering was necessary to improve the accuracy of the APD calculation algo-
rithm. After that, the action potential time traces were extracted across the
cardiac tissue. For each cycle length, times series of each pixel (pixel which
was filtered, not exactly single pixel) contain 50 elicited action potentials
as a result of 50 electrical pacing stimuli. Out of these 50 action potentials,
the last 30 action potentials were used for analysis. In order to calculate
APD50, the upstroke and downstroke of each action potential at 50% height
(50% repolarization) was calculated. APD50 was estimated as the difference
in time corresponding to action potential upstroke and downstroke at 50%
height. Similarly, APD70 was calculated from the upstroke and down stroke
of the action potential at 30% height (70% repolarization) (see Figure 5.1
for the definition of APD50 and APD70).
Electrical restitution of action potential duration
An example of a electrical restitution curve after administrating the heart with
Blebbistatin is shown in Figure 5.2 A. The APD50 is calculated for cycle lengths
between CL=500 ms to CL=135 ms. For cycle lengths below CL=135 ms,
ventricular fibrillation was induced during the pacing protocol. Hence these
cycle lengths were not used in the restitution analysis since the calculation of
APD is difficult during irregular ventricular fibrillation. APD for each cycle
length is calculated as the mean value of APDs from multiple pixels (≈ 5400)
on the left ventricular surface. Error bars represent the standard deviation
of APDs at these pixels, indicating the heterogeneity in APD50 on the left
ventricular surface (also minor measurement errors are also included). For
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each pixel, APD was calculated from 30 consecutive action potentials. These
30 action potentials were separated into odd and even action potentials in
order to detect APD alternans. Panel B (zoomed version of panel A, for lower
cycle lengths) shows APD alternans between CL=160 ms to CL=135 ms,








Fig. 5.2: APD restitution curve from a rabbit heart. The contraction of the heart was
suppressed by the administration of Blebbistatin (5.6 µM). A) APDs at 50%
repolarization( APD50) are plotted as a function of pacing cycle lengths
within the interval CL=500 ms to CL=135 ms. For each cycle length, the
APD50 is calculated as the mean value of APDs of ≈ 5400 pixels on the left
ventricular surface. Error bars represent the standard deviation of APDs
from these pixels. For each pixel, APD is calculated as the mean value of
30 consecutive action potentials (15 odd and 15 even). B) Zoomed version
of panel A, for lower cycle lengths, indicating the presence of alternans in
APD50.
5.2 Comparison of APDs in contracting and
Blebbistatin-uncoupled hearts during
electrical pacing
The robustness of combined motion stabilization and ratiometric techniques
allows the precise measurement of electrophysiological quantities such as
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action potential duration (APD) from contracting and deforming hearts.
Hence, this methodology is used to compare the action potential signals
CL=350 ms CL=190 ms




















Fig. 5.3: Comparison of action potentials obtained through ratiometric optical map-
ping from the surface of a Langendorff perfused rabbit heart in contracting
Blebbistatin-uncoupled conditions. The time series are obtained from
the ratio between the action potentials corresponding to blue and green
excitation wavelengths and are spatially averaged from 3 × 3 pixels A)
Representative action potential time series during electrical pacing at a
cycle length of CL= 350 ms (pacing frequency fp=2.86 Hz). B) Time series
of action potential at CL= 260 ms (pacing frequency fp= 3.85 Hz). C)
Obtained action potential time series at a cycle length CL=190 ms (pacing
frequency fp= 5.26 Hz). D) Action potential time series at a cycle length
CL=155 ms (pacing frequency fp= 6.45 Hz). For all the cycle lengths, the
APDs of the heart in Blebbistatin condition show significant prolongation
compared to the APDs of the contracting heart. Also at higher frequencies,
action potential time traces of the contracting heart become triangular
and the difference between APDs of Blebbistatin and contracting heart
increases.
in contracting and post Blebbistatin conditions. Figure 5.3 shows the com-
parison of action potential time traces obtained from the left ventricular
surface of a rabbit heart in contracting (after applying motion stabilization
and ratiometry) and non-contracting (electromechanically uncoupled with
Blebbistatin) conditions. Panel A, B, C and D of Figure 5.3 show the action
potential time series comparison in which the heart is electrically paced with
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the help of a local pacing electrode, with cycle lengths CL=350 ms, CL=260
ms, CL=190 ms and CL=155 ms, respectively. Action potential time series
with Blebbistatin shows significant prolongation in action potential duration
(APD) for all four cycle lengths. However, action potential shape becomes
triangular at CL=155 ms (or pacing frequency fp= 6.45 Hz). This is already
a high frequency stimulation as compared to the normal rhythm frequency
(≈2 Hz).
5.3 Comparison of restitution curves between
contracting and Blebbistatin-uncoupled
hearts
The dependency of action potential duration over a range of pacing fre-
quencies was calculated by electrically pacing the heart with progressively
shortened cycle lengths. The dynamic restitution protocol as described in sec-
tion 5.1.1 was used to electrically stimulate the heart, first in contracting and
then in Blebbistatin-uncoupled conditions. The restitution curve obtained
from a contracting heart is called electomechanical restitution to reflect the
presence of mechanical contraction in this restitution measurements. Once
again, marker-free motion tracking and ratiometric measurements were em-
ployed on contracting hearts. The action potential durations for 50% (APD50)
and 70% (APD70) repolarization were calculated as described in section 5.1.1
from contracting and Blebbistatin-uncoupled hearts. Figure 5.4 shows the
comparison of restitution curves of a single heart (N=1) in contracting and
Blebbistatin-uncoupled conditions (only APD50 is shown). The restitution
curve shows shortening of APD50 in contracting hearts for all cycle lengths in
the range CL=500 ms to CL=135 ms. In other words, there is a prolonga-
tion in APD50 with the administration of Blebbistatin. Due to the induction
of ventricular fibrillation during pacing, the APD50 measurement was not
possible for cycle lengths CL<135 ms in Blebbistatin-uncoupled condition.
The restitution curve in contracting condition shows larger error bars in APD
measurement in the interval CL=320 ms to CL=260 ms owing to the higher
motion amplitude of the heart at these pacing cycle lengths (see Figure 5.5).









Fig. 5.4: APD restitution curve for a single rabbit heart in contracting (red and
blue) and Blebbistatin-uncoupled (5.6 µM; black and green) conditions.
APDs at 50% repolarization (APD50) are plotted as a function of pacing
cycle lengths within the interval CL=500 ms to CL=100 ms. Calculation
of (APD50) was not possible for CL <135 ms in Blebbistatin administrated
condition due to the induction of ventricular fibrillation during pacing
at these cycle lengths. For each cycle length, the APD50 is calculated as
the mean value of APDs of ≈ 5400 pixels on the left ventricular surface.
Error bars represent the standard deviation of APDs from these pixels. For
each pixel, APD is calculated as the mean value of 30 consecutive action
potentials (15 odd and 15 even). The APDs are divided into odd and even
in order to detect APD alternans, which is visible at cycle lengths CL< 160
ms in post Blebbistatin condition, whereas in contracting (pre Blebbistatin)
condition, no clear APD alternans is visible until CL=110 ms.
Alternans in APD50 can be seen in restitution curves corresponding to
Blebbistatin conditions for cycle lengths in the pacing interval CL=160 ms to
CL=135 ms as indicated by the deviation of odd (black) and even (green)
APDs at these cycle lengths. Whereas, in contracting condition, no clear
APD alternas is noticeable though the restitution curves slightly splits after
CL=110 ms. Additionally, there was no induction of ventricular fibrillation
during the restitution protocol with contracting heart. Hence, these resti-
tution measurements show a link of APD alternans and cardiac arrhythmia
susceptibility as shown in previous studies [Kar93; Kar94; Tse+16].
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Though the heart used in Figure 5.4 is a typical example in terms of APD
restitution, the APD alternans were not observed in all the hearts which
were used to investigate restitution dynamics (observed in 2 out of 5 hearts).
However, this example was used to illustrate the possibility of the generation
of APD alternans and arrhythmias at high frequency electrical pacing.
5.4 Variation of action potential duration and
motion amplitude during electrical pacing




Fig. 5.5: APD restitution curve (blue) for a single rabbit heart (same as in Fig-
ure 5.4) in contracting condition and the displacement of the heart with
pacing cycle length (reddish brown). APD for each cycle length is cal-
culated from 15 consecutive odd action potentials. Error bars represent
the standard deviation of APDs along the ventricular surface. The cycle
lengths with larger error bars in the restitution curve coincide with dis-
placement maxima indicating larger displacement and deformation of the
heart resulting in less precise APD measurements.
Motion tracking produced displacements (in x and y directions) of the
cardiac tissue for each pixel and for each frame with respect to the reference
frame. The magnitudes of displacements in x and y directions were used
to calculate the resultant displacement vector ~d (x, y, t). The magnitude of
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the resultant displacement vector (in pixels) representing the amplitude of
motion (motion amplitude) is calculated for all the pacing cycle lengths in
the range CL=500 ms to CL=100 ms (pacing frequency in the range fp=2 Hz
to 10 Hz). For each cycle length, the time varying motion amplitude (see Fig-
ure 5.11) is averaged across the cardiac tissue (mean value is calculated from
all the pixels) and the effective motion amplitude is calculated either as the
maximum value of displacement (Max Displacement, reddish brown, solid)
or mean value of displacement (Mean Displacement, reddish brown, dashed),
along the frames. Figure 5.5 shows the variation of motion amplitude (dis-
placement in pixels) and action potential duration (APD50, blue) with pacing
frequencies for the same heart, which is used in Figure 5.4. The APD50 values
are same as mentioned there (contracting condition), but only odd APDs
are shown here. The APD50 and motion amplitude in general decrease with
decrease in pacing cycle length (or with an increase in pacing frequency).
But there exists a region of pacing interval (CL=320 ms to CL=260 ms)
characterized by a sharp drop in APD50 values with higher errorbars. The
larger errorbars of the restitution curve in this region coincide with a peak in
motion amplitude for nearly the same cycle lengths, confirming that, higher
amplitudes of contractile motion at these pacing frquencies cause inaccuracy
in APD measurements. These larger motion amplitudes at these frequencies
(≈ 3Hz to 4 Hz) are due to the mechanical resonance phenomenon associated
with the contracting heart, while hanging in a perfusion system.
5.5 Comparison of APD maps in contracting
and Blebbistatin-uncoupled hearts
The action potential duration (APD50) was calculated for all pixels in the
camera field of view representing the left ventricular surface in contracting
and Blebbistatin-uncoupled conditions. Figure 5.6 shows a typical example
of APD maps obtained with four different pacing cycle lengths at these
conditions. The analysis was performed for N=5 hearts and the observation
was consistent in all the hearts.
APD maps show the variation of APD50 across the left ventricular surface
of a rabbit heart (different from that shown in Figure 5.5) represented by
≈ 2900 pixels (≈1.3 cm2). APD for each pixel was calculated from the
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CL=350 ms CL=260 ms CL=200 ms CL=145ms
Fig. 5.6: Comparison of APD maps in contracting and Blebbistatin-uncoupled (5.6
µM) conditions for different pacing cycle lengths. Blebbistatin prolongs
action potential duration in all cycle lengths. Colorbar shows APD50 in ms.
Each APD map shows APD values of ≈ 2900 pixels, depicting the portion
of left ventricular surface (≈1.3 cm2).
action potential time series of that particular pixel as described in section
5.1.1. The average values of APD50 (mean value calculated from APD maps)
in contracting condition are 126 ± 6.72ms, 99 ± 5.68ms, 87 ± 4.91ms and
53±3.09ms for cycle lengths CL= 350 ms, CL= 260 ms, CL= 200 ms and CL=
145 ms, respectively. Similarly, the average values of APD50 in Blebbistatin-
uncoupled condition are 152 ± 6.76ms, 130 ± 6.16ms, 106 ± 6.0ms and
80 ± 5.29ms for cycle lengths CL= 350 ms, CL= 260 ms, CL= 200 ms
and CL= 145 ms, respectively. The APD maps depict the prolongation
of APDs in Blebbistatin-uncoupled condition as compared to contracting
condition for all the pixels across the heart tissue and for all cycle lengths.
On average, the APD maps show 22.75% shortening of APD50 in contracting
condition as compared to Blebbistatin-uncoupled condition. Figure 5.7 shows
the APD50 values of Figure 5.6 in contracting and Blebbistatin-uncoupled
conditions as histograms. APD50 values in contracting condition are shorter
than Blebbistatin-uncoupled condition for all cycle lengths used to pace the
heart (but only four cycle lengths are shown here). Additionally, APDs in
contracting condition, on average, show higher magnitudes of dispersion
compared to Blebbistatin condition.











CL=350 ms CL=260 ms CL=200 ms CL=145 ms
Fig. 5.7: Histogram of APD50 calculated from APD maps in contracting (top row)
and Blebbistatin (bottom row) conditions for four pacing cycle lengths.
APD50 values show prolongation in Blebbistatin condition for all cycle
lengths.
5.6 Electromechanical restitution curves from
multiple hearts
The restitution measurements in contracting and Blebbistatin-uncoupled
conditions were repeated for multiple hearts (N=5) and the comparison
results are displayed in Figure 5.8. APD values are calculated from 30
consecutive action potentials out of 50 elicited action potentials by the
application of 50 electrical stimuli as mentioned in section 5.1.1.
Panel A shows the average restitution measurements of APD50 from N=5
hearts in contracting (red) and Blebbistatin-uncoupled conditions (black).
The APD values are pooled from all the pixels (pixels used to make APD
maps) and all the hearts. Each data point is the mean of pooled APD50
corresponding to each cycle length and the error bars are standard deviations
from these pooled APD values. Higher magnitudes of error bars are due to
variations of APD values between different hearts. Even with the higher error
bars, there exists a significant prolongation of APD values with the adminis-
tration of Blebbistatin (or a shortening in contracting hearts as compared to
Blebbistatin-uncoupled condition).
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Fig. 5.8: Comparison of cardiac APD restitution curves for rabbit hearts in con-
tracting (red) and Blebbistatin (black) treated conditions for progressively
shortened pacing cycle lengths from CL= 260 ms to CL= 160 ms (pacing
frequency fp=3.84 Hz to fp=6.25 Hz). APDs calculated from 30 consecu-
tive action potentials (obtained from optical mapping data) for each cycle
length. A) Average APD50 restitution curve from N=5 hearts. Error bars
represent the standard deviation of all APDs pooled across all the pixels
and all the hearts. Large standard deviations indicate the dispersion of
APDs across multiple hearts. B) Average APD50 restitution curve for N=5
hearts. Error bars represent the mean of standard deviations of APD50
from individual hearts. C) Average APD70 restitution curve for N=5 hearts.
Error bars represent the mean of standard deviations of APD70s from
individual hearts. D-E) Comparison of APD50 restitution curves for two
different hearts. The error bars are calculated as the standard deviation
of APDs along the pixels F) Comparison of single pixel APD50 and APD70
restitution curves.
Panel B represents the average restitution curves of APD50 from N=5 hearts
(data points are same as in panel A) in contracting (red) and Blebbistatin-
uncoupled (black) condition, with errorbars calculated as the mean of stan-
dard deviations of APDs from these 5 hearts. The standard deviation for each
heart is calculated from APD50 values of all the pixels. The comparatively
larger error bars show the measurement uncertainty in contracting hearts
due to residual motion artifacts. However, the restitution curves significantly
differ between contracting and Blebbistatin conditions.
Panel C displays the average restitution curves of APD70 (contracting: red,
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Blebbistatin: black) for N=5 hearts, data points are averages of pooled APD70
from all the pixels (same pixels used for APD50 calculation) and all the hearts.
Error bars represent mean of the standard deviations of all the N=5 hearts.
The standard deviation for each heart is calculated from APD70 values of all
the pixels.
Panel D and E represent the comparison of APD50 restitution curves in con-
tracting and Blebbistatin-uncoupled conditions for two different hearts. Data
points are the mean APD50 along the pixels and error bars represent the stan-
dard deviations of APD50 from all the pixels. Larger error bars in contracting
condition show the measurement inaccuracy owing to the residual motion
artifacts which persist in some pixels even after motion compensation.
Panel F shows the single pixel restitution curves of APD50 and APD70 in con-
tracting and Blebbistatin-uncoupled conditions. APDs (APD50 and APD70)
show prolongation in Blebbistatin-uncoupled condition as compared to con-
tracting condition. The mean errorbars computed with contracting hearts are
2.1 ± 0.4 and 1.7 ± 0.2 for APD50 and APD70, respectively. And the average
error bars in Blebbistatin-uncoupled condition are 1.4± 0.15 and 1.0± 0.13
for APD50 and APD70, respectively. The smaller error bars (in contracting and
Blebbistatin-uncoupled conditions) show the accuracy of single pixel APD
calculation.
5.7 Variation of action potential duration and
restitution properties with Blebbistatin
concentration
To analyze the variation of action potential duration with the change in Bleb-
bistatin concentrations, the Blebbistatin was administrated to the contracting
hearts in multiple steps such that at each step 0.7 µM of Blebbistatin was
added to the perfusion bath until a final concentration of 2.8 µM was reached,
where the amplitude of contraction became small (≈ 1 pixel). There was
a waiting time of about 20 minutes after adding each Blebbistatin concen-
tration in order to give enough time for Blebbistatin’s action. The hearts
were progressively paced first in contracting condition and then with each
Blebbistatin concentrations using the dynamic restitution protocol. The elec-
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tromechanical properties of the hearts were calculated after compensating
the motion using motion tracking and ratiometry in contracting condition as
well as in all the Blebbistatin concentrations. Figure 5.9 shows the variation
of action potential duration, amplitude of contractile motion and restitution
curve with the concentration of Blebbistatin (red: 0 µM (contracting), light
gray-black: Blebbistatin 0.7-2.8 µM)
Panel A shows the variation of a single action potential trace (obtained during
electrical pacing with a cycle length CL=180 ms in optical mapping exper-
iments) with different Blebbistatin concentrations (0 µM, 0.7 µM, 1.4 µM,
2.1 µM and 2.8 µM). 0 µM corresponds to fully-contracting condition of the
heart in the absence of Blebbistatin. The time traces (optical action potential,
Inorm is the normalized fluorescent intensity modulated by action potential)
were obtained after spatial averaging of 3× 3 pixels from the left ventricular
surface. The action potential duration (APD50) in contracting condition is 68
ms. APD50 increases with each Blebbistatin concentration such that APD50
becomes 80 ms with 0.7 µM, 96 ms with 1.4 µM and 100 ms with both 2.1
µM and 2.8 µM, indicating a saturation in APD values for higher Blebbistatin
concentration.
Panel B shows the variation of contractile motion amplitude of the heart
with Blebbistatin concentration. The motion amplitude was calculated as
mentioned in section 5.4. Upper row shows the maximum amplitude of
motion, whereas lower row shows mean amplitude of motion for CL=180
ms. The maximum amplitude motion decreases from ≈ 5 pixels to ≈ 1 pixel
and the average amplitude of motion decreases from ≈ 3 pixels to ≈ 0.6
pixel for the change in Blebbistatin concentration from 0 µM to 2.8 µM.
Panel C represents the variation of APD50 restitution curve with Blebbistatin
concentration. Restitution curves show prolongation of APD50 with Bleb-
bistatin in a dose-dependent manner. Error bars become smaller with each
concentration for all cycle lengths showing the reduction of residual motion
artifacts as a consequence of reduction in motion amplitude as shown in
panel B.
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Fig. 5.9: Effect of Blebbistatin concentration (0 µM - 2.8 µM) on the electromechan-
ical properties of the cardiac tissue. A) Dependence of action potential
duration (APD50) on Blebbistatin concentration during electrical pacing
with CL=180 ms. Inorm represents the action potential modulated fluo-
rescent intensity (normalized). Time traces were obtained after spatial
averaging of 3 × 3 pixels from the left ventricular surface. B) Variation
of the contractile motion amplitude (maximum and average) with the
concentration of Blebbistatin. C) Variation of APD50 restitution curve with
Blebbbistatin concentration showing the prolongation of APD50 for all
cycle lengths.
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5.8 Variation of action potential duration with
Blebbistatin washout
To examine the reversibility of electrophysiolgical properties of the hearts,
Blebbistatin was washed out from N=2 hearts by perfusing the hearts with a
fresh Tyrode solution for 60-100 minutes. The hearts started to beat during
the washout process and the dynamic restitution protocol was used to electri-
cally pace the hearts. Motion tracking and ratiometric measurements were
applied on these moving hearts in order to measure the electrophysiological
properties. The action potential signals produced during washout were com-












Fig. 5.10: Changes in action potential duration with washout of Blebbistatin. A)
Comparison of action potential time traces obtained from 5×5 pixels from
the left ventricular surface of a rabbit heart in Blebbistatin-uncoupled
(black) and Blebbistatin-washout (green) conditions. Action potential du-
rations shorten with the washout of Blebbistatin. B) APD maps showing
spatial variation of action potential durations (APD50) across the left ven-
tricular surface in Blebbistatin-uncoupled (upper row) and Blebbistatin-
washout (lower row) conditions. APD map with washout shows short-
ening of action potential durations for all pixels (representing the left
ventricular surface) in comparison with Blebbistatin condition.
5.8 Variation of action potential duration with Blebbistatin
washout
61
Figure 5.10 shows the comparison of action potential durations in Blebbista-
tin-uncoupled and Blebbistatin-washout conditions. Panel A shows time
traces (spatial averaged from 5×5 pixels) from the left ventricular surface
of a rabbit heart in Blebbistatin-uncoupled (black; heart is not contracting)
and Blebbistatin-washout (green; heart is contracting) conditions. The high
spatial smoothing was used due to low signal to noise ratio of the optical
action potential traces after the long waiting time (washout time ≈100
minutes) during the experiment. The action potential duration decreases with
Blebbistatin washout. Panel B shows the APD maps in Blebbistatin-uncoupled
(upper row) and Blebbistatin-washout (lower row) conditions. The APD map
in Blebbistatin-washout condition shows shortening of APD50 for all the pixels
as compared to APD map of Blebbistatin-uncoupled conditions. This result is
consistent with the findings of Figure 5.6, where action potential duration
shows prolongation with Blebbistatin as compared to contracting condition.
In short, administration of Blebbistatin to a contracting heart prolongs its
action potential duration. APD comes back to shorter values upon washing
out of the Blebbistatin. This implies that Blebbistatin-dependent APD changes
are reversible.
5.9 Impact of pacing frequency on
electromechanical coupling
To determine how the electrical activity affects the mechanical properties
of the hearts, ratiometric optical mapping as described in section 3.2 was
performed in contracting rabbit hearts during electrical pacing. The action
potential time traces were extracted from the ratio video images of motion
stabilized hearts (with motion tracking). The motion tracked data of either
blue or green elicited action potentials were used to calculate motion am-
plitude as described in section 5.4. Figure 5.11 shows time traces of action
potentials (green) and motion amplitudes (red) and the corresponding power
spectra (calculated using Fourier transform of the time traces; green for ac-
tion potential and red for motion amplitude) of both these traces for eight
different pacing cycle lengths.
The action potentials and motion amplitudes were spatially averaged over
all pixels for each cycle length. The panels A-H show the action potentials,
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Fig. 5.11: Effect of pacing frequency on the electromechanical properties of the
heart. Time series and corresponding power spectra of action potential
(green) and motion amplitude (red) for different pacing frequencies
(or pacing cycle length CL). Time series of action potential and motion
amplitude were spatially averaged over all pixels representing the cardiac
tissue. A) Time series and power spectra of action potential and motion
amplitude for CL=350 ms (pacing frequency fp=2.86 Hz) B) Corresponds
to CL=280 ms (pacing frequency fp=3.57 Hz) C) For CL=240 ms (pacing
frequency fp=4.17 Hz) D) For CL=190 ms (pacing frequency fp=5.26
Hz) E) For CL=160 ms (pacing frequency fp=6.25 Hz) F) For CL=140
ms (pacing frequency fp=7.14 Hz) G) For CL=125 ms (pacing frequency
fp=8 Hz) H) For CL=110 ms (pacing frequency fp=9.09 Hz)
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motion amplitudes and their power spectra for cycle lengths CL=350 ms,
CL=280 ms, CL=240 ms, CL=190 ms, CL=160 ms, CL=140 ms, CL=125 ms
and CL=110 ms, respectively. Action potential and motion amplitude are
well coupled for all lower frequency stimulation until CL=140 ms (pacing
frequency fp=7.14 Hz) as indicated by the identical frequencies in the power
spectra of these electromechanical activities. For pacing frequencies higher
than 7.14 Hz, the action potential and motion amplitude time traces are
not well coupled which results in the shift of the dominant frequency of the
motion amplitude from that of the action potential for pacing frequencies
values of fp=8 Hz (CL=125 ms) and fp=9.09 Hz (CL=110 ms).
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An important method to characterize lethal ventricular fibrillation (VF) is
by calculating the dominant frequency of electrical wave propagation using
FFT (Fast Fourier Transform) based Fourier domain power spectra analysis.
The dominant frequency of VF is usually defined as the largest peak in the
FFT spectrum of the optical action potential signal [Val+02]. However, VF
is chaotic and the FFT spectrum contains more frequency components with
significant spectral powers in them, in addition to the dominant peak. Hence,
selecting the dominant peak alone to calculate VF frequency is questionable.
This chapter addresses the issue of dominant frequency calculation by using
a weighted dominant frequency approach instead of dominant frequency
itself. The weighted dominant frequencies were calculated for N=10 rabbit
hearts in contracting and in non-contracting (with Blebbistatin) conditions
and a systematic comparison of frequencies in both these conditions is also
shown. Motion tracking and ratiometric measurements were used to extract
the action potential time traces from contracting hearts during ventricular fib-
rillation. Ratiometric measurements were used in all Blebbistatin uncoupled-
conditions and the combined motion tracking and ratiometry were applied
in hearts having slight movements even after Blebbistatin administration
(N=1).
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6.1 Induction of ventricular fibrillation
Ventricular fibrillation was often induced as a result of a dynamic pacing
protocol with a local pacing electrode as described in section 5.1.1. This
protocol was used for VF induction in N=7 hearts. For N=3 hearts, VF was
induced by pacing the heart with the same local pacing electrode by applying
high frequency (usually 30-50 Hz) electrical pulses for 10-30 seconds. Unsuc-
cessful inductions were repeated either with the same frequency electrical
pulses or with a slightly different value of frequency until fibrillation was
induced.
6.2 Dominant and weighted dominant frequen-
cies of ventricular fibrillation
To determine the dominant frequency of the hearts during ventricular fib-
rillation, action potential time traces were extracted from contracting and
Blebbistatin-uncoupled hearts. The dominant frequencies were calculated
for all the pixels (representing the left ventricle) as the frequencies corre-
sponding to the largest peak in the action potential power spectra. Pixel wise
dominant frequencies were used to construct dominant frequency maps.
Figure 6.1 shows dominant frequency maps and Fourier power spectra of
optical action potential time traces during ventricular fibrillation across the
left ventricular tissue in contracting and Blebbistatin-uncoupled conditions.
The dominant frequency for each pixel was calculated as the frequency
corresponding to the largest peak of the power spectrum. Panel A shows the
dominant frequency map in contracting condition calculated from optical
action potentials of 8 second duration. The dominant frequency map shows
heterogeneity in dominant frequencies across the left ventricular tissue. Panel
B shows optical action potential power spectrum in contracting condition
for four different pixels (pixels represented by 1,2,3 and 4 in panel A)
with dominant frequencies of 15.26 Hz, 13.43 Hz, 20.75 Hz and 9.88 Hz,
respectively.
Similarly, panel C shows the dominant frequency map and power spectra
of the same heart after Blebbistatin administration. The dominant frequency
map with Blebbistatin exhibits homogeneous distribution of dominant fre-
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Fig. 6.1: Ventricular fibrillation frequency map and power spectra from a rabbit
heart in contracting and Blebbistatin-uncoupled (2.8 µM) conditions. A)
Dominant frequency map showing dominant frequencies of action po-
tential across the left ventricular heart tissue in contracting condition.
The dominant frequency was calculated as the frequency corresponding
to largest peak in the FFT spectrum. B) Optical action potential power
spectra of four different pixels in contracting condition with dominant
frequencies at 15.26 Hz, 13.43 Hz, 20.75 Hz and 9.88 Hz, respectively.
C) Dominant frequency map of VF in Blebbistatin-uncoupled condition
D) Power spectra from four different pixels in Blebbistatin-uncoupled
condition with dominant frequencies at 8.30 Hz, 10.13 Hz, 10.13 Hz and
10.13 Hz, respectively. The power spectra and dominant frequencies were
computed from optical action potential time traces of 8 second duration.
6.2 Dominant and weighted dominant frequen-
cies of ventricular fibrillation
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quencies across the heart tissue as compared to the contracting condition.
Power spectra of four different pixels are also partially similar with dominant







Fig. 6.2: Histogram of dominant frequency map showing dominant frequency of
the rabbit heart during ventricular fibrillation in contracting (red) and in
Blebbistatin (2.8 µM;black) conditions. The dominant frequencies were
calculated from dominant frequency maps.
Figure 6.2 shows the comparison of dominant frequencies of the heart in
contracting and Blebbistatin-uncoupled conditions as a histogram (dominant
frequencies were calculated from dominant frequency maps as shown in
Figure 6.1A and Figure 6.1C). Significant reduction in dominant frequencies
of ventricular fibrillation is noticeable in Blebbistatin administrated con-
dition as compared to contracting condition. Also, dominant frequencies
in contracting condition are spatially more dispersed in comparison with
Blebbistatin-coupled condition.
The power spectra in Figure 6.1B and Figure 6.1D indicate that there
is significant spectral power in frequency components in addition to the
dominant peaks (see panel B4 and panel D3). Hence, selecting the largest
peak of the power spectrum as the dominant frequency excludes information
of other frequency components which have noticeable spectral power in
the FFT spectra. In order to include the contribution of other frequency
components, a weighted dominant frequency is defined and calculated for
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, Pi > Pth (6.1)
Where, fi represents the ith frequency component in the power spectrum such
that corresponding power Pi is greater than the threshold value Pth. The
equation (6.1) is used to avoid biasing in selecting a single frequency when
the dominant frequency is not predominant due to the presence of multiple













Fig. 6.3: Calculation of weighted dominant frequency. Example of a broadened
power spectrum from a contracting rabbit heart during ventricular fibril-
lation. Weighted dominant frequency is calculated by using the powers
greater than the threshold value Pth (60% in this case) and the corre-
sponding frequencies.
An example of a broadened FFT spectra (normalized) is shown in Fig-
ure 6.3. There are three frequency values (f1, f2 and f3) having spectral
powers (P1, P2 and P3) higher than the threshold Pth. In this example, select-
ing a single dominant frequency (f2) completely ignores the contributions of
f1 and f3 even though they contain noticeable spectral powers. The power
threshold is kept at 60% of the maximum power (Pmax=1, due to normaliza-
tion) only to demonstrate the calculation of weighted dominant frequency.
However, this threshold can, in theory, take any other values in the range
6.2 Dominant and weighted dominant frequen-
cies of ventricular fibrillation
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0-100%. In order to see the effect of the power threshold on the weighted
dominant frequency, five different threshold values such as 70%, 50%, 30%,
10% and 0% of the maximum power were used. The weighted dominant
frequency is calculated by weighting the frequency components which are
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Fig. 6.4: Frequency maps showing weighted dominant frequencies of a rabbit heart
in contracting (upper row; with motion stabilization and ratiometry) and
Blebbistatin-uncoupled (lower row; 2.8 µM) conditions. Frequency maps
from left to right (except the first left column) show the variation of
weighted dominant frequencies with different power thresholds (Pth).
Weighted dominant frequency is calculated by weighting the frequency
components which are above the threshold value in the power spectrum.
The frequency maps on the first left column (Dominant frequency) show
the spatial variation of dominant frequency, calculated by selecting the
largest peak in the power spectrum without giving weight to other fre-
quency components.
Figure 6.4 illustrates the change in frequency maps of ventricular fibrilla-
tion with different power threshold in contracting and Blebbistatin-uncoupled
(2.8 µM) conditions for a single heart (same heart used in Figure 6.1). Dom-
inant frequency maps (left raw; dominant frequency) were calculated by
selecting the largest peaks in the power spectra without giving any weight
to other frequency components and they are same as the frequency maps
shown in Figure 6.1A and Figure 6.1C. Weighted dominant frequency maps
with different power threshold display slightly different frequency values and
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the frequency maps undergo smoothing behavior as we decreases the power
threshold. The small rise in frequency values with a power threshold of 0%
is due to the presence of high frequency noise values while weighting all the
frequency components within the power spectrum. However, the difference
in the dominant frequencies of the heart in contracting and Blebbistatin-
uncoupled conditions is still consistent even after giving weight to other












Fig. 6.5: Histogram showing dominant frequencies of a single rabbit heart during
ventricular fibrillation in contracting (left: red and brown) and in 2.8 µM
Blebbistatin (right: black and gray) conditions. Upper raw (red and black)
corresponds to dominant frequencies (DF) obtained from the largest peaks
of the power spectra and lower raw shows weighted dominant frequencies
(WDF) obtained from multiple peaks with a power threshold (Pth) of 50%
(brown and gray).
The same effect is also salient in the histogram shown in Figure 6.5, where
the dominant frequency (DF) and weighted dominant frequencies (WDF at
50% power threshold) are within 10-20 Hz in contracting condition and are
around 10 Hz for Blebbistatin-uncoupled condition. Hence, it confirms that,
the observed effect in the dominant frequency is due to the administration of
Blebbistatin and not due to any bias in frequency calculation.
Figure 6.6 shows the variation of weighted dominant frequencies (except
the first two bars on the left) in contracting and Blebbistatin-uncoupled
conditions for different power thresholds. The first two bars represent
6.2 Dominant and weighted dominant frequen-












Fig. 6.6: Bar plot showing dominant frequencies of ventricular fibrillation from
a contracting (red) and Blebbistatin-uncoupled (black) rabbit heart for
different power thresholds. Error bars show the standard deviation of VF
frequencies calculated from the frequency maps shown in Figure 6.4.
dominant frequencies in contracting and Blebbistatin conditions, respectively.
The bar plots represent the mean and standard deviation of VF frequencies
calculated from the frequency maps shown in Figure 6.4. The frequencies of
VF in contracting condition are 15.36± 3.19 Hz, 15.34± 2.87 Hz, 15.27± 2.66
Hz, 15.19 ± 2.41 Hz, 15.14 ± 2.22 Hz and 16.14 ± 2.16 Hz corresponding to
the frequency calculation methods such as dominant frequency, Pth= 70%,
Pth= 50%, Pth= 30%, Pth= 10% and Pth= 0%, respectively. Similarly, the
frequency values in Blebbistatin condition are 9.48± 0.99 Hz, 9.47± 0.92 Hz,
9.48±0.84 Hz, 9.41±0.76 Hz, 9.24±0.65 Hz and 10.77±0.83 Hz corresponding
to dominant frequency, Pth= 70%, Pth= 50%, Pth= 30%, Pth= 10% and
Pth= 0%, respectively. The mean and standard deviation of frequencies
on average decreases as we go from dominant frequency to Pth= 10% due
to the inclusion of lower frequency components from the power spectra in
addition to the largest peak. For Pth= 0%, all the frequency values and the
corresponding power in the power spectra are used to calculate weighted
dominant frequency. The weighted dominant frequency in this case shows
an increase in the mean value due to the presence of high frequency noise in
the power spectra.
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6.3 Variation of ventricular fibrillation frequen-
cies with Blebbistatin concentration
Variation of ventricular fibrillation frequencies with different Blebbistatin
concentrations (0-2.8 µM) was investigated and the frequency maps contain-
ing dominant (upper row) and weighted dominant frequencies (lower row;
Pth=50%) are shown in Figure 6.7.
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Fig. 6.7: Frequency maps showing the variation of ventricular fibrillation frequency
with Blebbistatin concentration. Upper row shows the dominant frequency
maps calculated from the largest peaks of the power spectra and lower row
corresponds to weighted dominant frequency calculated from multiple
peaks with 50% power threshold (Pth). Significant change in dominant fre-
quency is observed with 0.7 µM of Blebbistatin concentration, whereas the
changes in frequencies are not very significant with higher concentration.
From 0 µM to 0.7 µM of Blebbistatin, the maximum change in VF frequency
is observed. After that, slight changes in frequencies (dominant frequency
from 9.74 Hz to 9.48 Hz, weighted dominant frequency from 9.80 Hz to 9.48
Hz) is noticed with the increase in Blebbistatin concentration from 0.7 µM to
2.8 µM.
The bar plots in Figure 6.8 display the change in ventricular fibrillation
frequencies (mean and standard deviation calculated from frequency maps)
6.3 Variation of ventricular fibrillation frequen-
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Fig. 6.8: Ventricular fibrillation dynamics with Blebbistatin concentration. A) Bar
plots showing the mean and standard deviation of VF frequencies calcu-
lated with dominant frequency (red and black) and weighted dominant
frequency (50% power threshold; reddish brown and dark green) ap-
proaches for different Blebbistatin concentrations (0, 0.7, 1.4, 2.1 and 2.8
µM). Error bars represent the standard deviation of dominant frequencies
from multiple pixels along the left ventricle (calculated from frequency
maps shown in Figure 6.7). B) Spatial variation of displacement (in pixels)
of the heart during ventricular fibrillation in fully contracting (0 µM) and
Blebbistatin (2.8 µM) conditions.
for different Blebbistatin concentrations such as 0 µM, 0.7 µM, 1.4 µM,
2.1 µM and 2.8 µM. Blebbistatin concentration of 0 µM represents a fully
contracting heart with an average displacement of 1.13 pixels. At 2.8 µM,
the displacement of the heart becomes negligible (average displacement=
0.16 pixel). Adding 0.7 µM of Blebbistatin to the contracting heart pro-
duced significant decrease (≈ 35%) in dominant and weighted dominant
frequencies. Increasing the concentration of Blebbistatin further decreases
the frequencies slightly. The bar plots show dominant frequencies values of
15.36±3.19Hz, 9.74±1.32Hz, 9.70±0.94Hz, 9.35±0.65Hz, 9.48±0.99Hz
corresponding to the Blebbistatin concentration of 0 µM, 0.7 µM, 1.4 µM, 2.1
µM and 2.8 µM, respectively. The weighted dominant frequencies (Pth=50%)
for these concentrations are 15.27± 2.66Hz, 9.80± 1.11Hz, 9.76± 0.73Hz,
9.40± 0.51Hz, 9.48± 0.84Hz, respectively.
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6.4 Ventricular fibrillation frequencies from
multiple hearts
All the frequency analysis of previous sections were carried out for a sin-
gle heart (Heart 8 in Figure 6.9). This section focuses on the analysis of
ventricular fibrillation frequencies for multiple hearts. The VF frequency mea-
surements were repeated for N=10 rabbit hearts and the comparison of the
frequencies (weighted dominant frequencies with Pth=50%) in contracting












Fig. 6.9: Bar plot showing the comparison of weighted dominant frequencies
(Pth=50%) of ventricular fibrillation for 10 hearts in contracting heart
(red) and Blebbistatin-uncoupled (black) conditions. The error bars rep-
resent the standard deviation of frequencies calculated from frequency
maps. The weighted dominant frequencies for each heart was calculated
from time traces consisting of 8 seconds duration.
The bar plots show the mean and standard deviations of VF frequencies
calculated from the corresponding frequency maps. VF was induced with
dynamic pacing protocol in 7 hearts (hearts 2-8), whereas for 3 hearts (hearts
1, 9, 10) VF induction was done by pacing with high frequency electrical
pulses as mentioned in 6.1.
The Blebbistatin concentration for N=8 hearts was 5.6 µM and the con-
centration for N=2 hearts (heart 8 and heart 9) was 2.8 µM, where the
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Fig. 6.10: Weighted dominant frequency comparison (Pth=50%) between contract-
ing and Blebbistatin-uncoupled hearts during ventricular fibrillation. A)
Frequency maps (for N=10 hearts) of left ventricular tissue showing
higher frequency of ventricular fibrillation in contracting hearts as com-
pared to Blebbistatin-uncoupled conditions. B) Time series of VF from
heart 5 (shown only for 3 seconds). Time traces are extracted from the
pixel shown in the center (as a black dot) after spatio-temporal averaging
the video frames with a window of size 3×3×3. C) Power spectrum calcu-
lated from panel B (but with time traces of 8 seconds duration with 2000
samples). D) Bar plot showing the average dominant frequency from 10
hearts indicating significant variation of VF frequencies in contracting
versus Blebbistatin-uncoupled hearts.
concentration was progressively increased until 2.8 µM to investigate the
concentration dependency of VF frequencies. All hearts except heart 7 show
decrease in VF frequencies in Blebbistatin-uncoupled condition as compared
to contracting condition. Additionally, the standard deviation of frequen-
cies in contracting condition for these N=9 hearts are higher than in the
Blebbistatin case, indicating high spatial dispersion of frequencies across the
left ventricle during contraction. Heart 7 does not show changes in mean
value of frequencies in contracting and Blebbistatin conditions. But it is to be
noted that unlike all other hearts, the standard deviation of frequencies in
Blebbistatin condition is higher than in contracting condition. On average,
the VF frequencies in contracting and Blebbistatin conditions are 13 ± 3.5
and 8± 1.5, respectively. Hence, VF dynamics in contracting condition are
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characterized by higher frequency of electrical excitation as compared to
Blebbistatin-uncoupled conditions irrespective of the protocol used to induce
VF.
Figure 6.10 shows a more detailed analysis of VF dynamics in contracting
and Blebbistatin-uncoupled conditions. Panel A shows the frequency maps
for N=10 hearts in these conditions. Panel B shows exemplary time traces
from heart 5 (time traces extracted from the pixels denoted by the black
dot in the center). Panel C shows the frequency domain power spectrum
calculated from the time traces shown in panel B. For frequency calculation 8
second duration time traces were used. The blue dashed lines at Pnorm=0.5
shows 50% power threshold used to calculate weighted dominant frequency.
Panel D shows mean and standard deviations of VF frequencies calculated
from all N=10 hearts. Panels A-D in general show accelerated VF dynamics
in contracting hearts as compared to Blebbistatin-uncoupled hearts. In other
words, administration of Blebbistatin reduced VF dynamics in 9 out of N=10
hearts. On average VF frequencies in contracting hearts are 62% higher than
in Blebbistatin condition.
6.5 Variation of ventricular fibrillation
frequencies with Blebbistatin washout
Similar to the observation in section 5.8, Blebbistatin washout was em-
ployed in N=2 rabbit hearts for 60-100 minutes. Figure 6.11 illustrates
the comparison of optical action potential time traces in contracting (red),
Blebbistatin-uncoupled (1.4 µM); black) and Blebbistatin washout (green)
conditions from a single heart (heart 9 of Figure 6.10). Similar to the find-
ings of section 6.4, VF frequency of the contracting heart decreased from
WDF=10.62 Hz to WDF=5.55 Hz with Blebbistatin-administration. After
washing out the Blebbistatin for ≈100 minutes, the VF frequency increased
to 7.02 Hz. This indicates reversibility of VF frequencies with Blebbistatin
washout. However, the frequency value in washout condition lies in between
frequencies of contracting and Blebbistatin-uncoupled conditions, suggesting
that reversibility of VF dynamics is only partial.
































Fig. 6.11: Variation of VF frequencies with Blebbistatin washout. Optical ac-
tion potential time traces during ventricular fibrillation in contracting,
Blebbistatin-uncoupled (1.4 µM) and Blebbistatin-washout conditions
from a single heart. Irregular and high frequency VF activities become
more regular and slower with Blebbistatin (induction of VF was very dif-
ficult with Blebbistatin). Upon washout of Blebbistatin for 100 minutes,
an increase in VF frequency is observed with a frequency value that lies
in between that of contracting and Blebbistatin-uncoupled conditions.
6.6 Comparison of ventricular fibrillation
frequencies calculated from ECG and
optical data
The robustness of the frequency measurements were examined by calculating
the VF frequencies using optical action potential and ECG time traces for
N=2 hearts (heart 5 and heart 8 of Figure 6.10). Figure 6.12 shows the
comparison of Fourier power spectra from heart 5 (panel A) and heart 8
(panel B) using ECG (upper row) and optical action potential traces (lower
row) in contracting (red) and Blebbistatin-uncoupled (black) conditions.
Optical power spectra (power spectra from optical action potential traces)
were calculated by averaging the Fourier power from all pixels (pixels used
to create frequency maps). The green and blue dashed lines in the case
of optical data represent mean values of weighted dominant frequencies
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in contracting and Blebbistatin conditions calculated from corresponding










Fig. 6.12: Comparison of VF power spectra (normalized) calculated with ECG
(upper row) and optical action potential (lower row) for two different
rabbit hearts (panel A and B). Optical power spectra were calculated
by averaging the Fourier power from all pixels used to calculate the
frequency maps. Red spectra represent contracting condition, whereas
black spectra correspond to Blebbistatin condition. The green and blue
dashed lines represent mean values of weighted dominant frequency
maps (with Pth=50%) in contracting and Blebbistatin conditions, respec-
tively. Overall, power spectra in contracting condition are broader than
in Blebbistatin condition. The VF frequencies in contracting condition
are higher in both the hearts independent of the type of signals (ECG or
optical) used to calculate the frequencies.
The VF frequencies are higher in contracting hearts as compared to
Blebbistatin-uncoupled hearts independent of the signal (ECG or optical)
used to compute them. The peaks of the power spectra computed from
optical data show significant variation from the peaks of ECG power spectra
in panel A, indicating variation among VF frequencies when computed with
different types of time traces. But in panel B, the VF frequencies do not
show a noticeable change between ECG and optical action potential. Over-
all, VF power spectra in contracting hearts are broadened as compared to
Blebbistatin-uncoupled hearts. Though the exact reason for this mismatch
in frequencies computed with ECG and optical action potential in panel A
6.6 Comparison of ventricular fibrillation frequencies
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is unknown, a possible explanation is based on the difference in recording
locations of these two signals. The ECG signals are the average electrical
activity recorded from the whole heart, whereas optical action potentials
were recorded from the portion of heart (usually left ventricle) imaged by a
single camera. Additionally, the VF frequencies need not be homogeneous on
different locations of the heart as indicated by the spatial dispersion of fre-
quencies across the heart in Figure 6.10. Since the data recorded by a single
detector is used for optical mapping studies, the spatio-temporal dynamics of
VF on other regions of the heart is unknown. Hence, for proper comparison
VF frequencies using ECG and optical data, more detectors should be used to
record action potential from all regions of the heart. However, both ECG and




DF [Hz] WDF [Hz] DF [Hz] WDF [Hz]
1 ECG 18.69 18.68 11.84 11.80
Optical-power average 15.38 13.94 7.20 6.83
Optical-frequency map 14.07 14.23 7.57 7.50
2 ECG 15.64 13.07 10.34 10.28
Optical-power average 13.79 15.17 10.14 9.79
Optical-frequency map 15.36 15.27 9.48 9.48
Tab. 6.1: Comparison of dominant frequencies (DF) and weighted dominant fre-
quencies (WDF) for N=2 hearts computed with ECG and optical action
potential time traces (using Fourier power average and frequency maps).
The frequency values computed with ECG and optical action potential
time traces are tabulated in Table 6.1. Frequencies with optical action
potentials were computed using averaged Fourier power spectra (Optical-
power average) and also by using frequency maps (Optical-frequency map;
frequency was computed as the mean value of frequency maps). In all these
three cases, the frequencies were calculated with dominant frequency (DF)
and weighted dominant frequency (WDF) approaches.
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This thesis focused on the measurement of electrophysiological and mechani-
cal properties of contracting hearts by using marker-free numerical motion
tracking and ratiometric optical mapping techniques. The marker-free motion
tracking substantially reduced motion artifacts due to the relative motion
between the cardiac tissue and the camera, while excitation ratiometric
technique (using blue and green excitation light) was used to minimize dye
concentration and illumination artifacts. Illumination artifacts were mini-
mized by arranging the blue and green light sources around the heart to
achieve uniform illumination on ratio images during the experiment. The
combination of these two techniques significantly removed total motion arti-
facts from optical action potential signals. And these techniques were used
to measure electrophysiological properties such as action potential duration
and electromechanical restitution, more precisely from contracting hearts in
the absence of electromechanical uncouplers. Besides these, the combined
motion tracking and ratiometry was applied to visualize and characterize the
dynamics of ventricular fibrillation. Systematic comparisons of cardiac action
potential duration, cardiac restitution and ventricular fibrillation dynamics
were made in contracting and contraction-inhibited (pharmacologically with
Blebbistatin) conditions.
The action potential durations (APD50) of the contracting rabbit hearts
were measured from single pixels (after smoothing) with a precision of
2.1± 0.4ms, whereas the APD50 of Blebbistatin-uncoupled hearts were mea-
sured with a precision of 1.4± 0.15 ms. Comparison of electrophysiological
parameters showed on average 27± 5% (N=5 hearts) shortening of action
potential duration in contracting hearts compared to Blebbistatin-uncoupled
non-contracting hearts. The frequency of ventricular fiibrillation was found to
be significantly different between contracting (13± 3.5 Hz) and Blebbistatin-
uncoupled (8±1.5 Hz) conditions (N=10 hearts). Electrophysiological effects
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of Blebbistatin was found to be concentration-dependent and the effects were
reversible by washout of Blebbistatin (N=2 hearts) using fresh Tyrode’s
solution.
The observed differences in electrophysiological parameters between con-
tracting and Blebbistatin-uncoupled hearts are in agreement with previous
findings by Brack et al.[Bra+13] and Lee et al. [Lee+19]. Brack et al.
observed a prolongation (≈ 30%) of monophasic action potential duration
(APD90) in Blebbistatin-uncoupled condition when measured it electrically
from the base and apex of New Zealand White rabbit hearts (N=8) using
quadripolar contact electrodes. They have also observed prolongation in
optical action potential durations (≈ 27%) from the mid-wall region of the
left ventricle (less motion) in N=4 hearts. Another interesting observation
of them is the increase in ventricular fibrillation threshold in Blebbistatin-
uncoupled condition. The findings shown in this thesis partially confirms
their observation. Eventhough the studies shown here did not compute the
threshold of VF induction, it was difficult to induce VF with Blebbistatin in
N=4 hearts (out of N=10). On the other hand, induction of VF in contracting
condition was more easy to achieve in N=9 hearts. Recently in 2019, Lee
et al. observed prolongation (≈18%) of APD90 in Langendorff perfused pig
hearts in Blebbistatin-uncoupled condition using ratiometric optical mapping
recordings. However, those studies were unable to remove motion artifacts
originating from all the different sources as mentioned in this thesis. Addi-
tionally, those studies only measured action potentials (optical or electrical)
from limited number of locations).
However, the effect of Blebbistatin on cardiac electrophysiology is still a
controversial topic. During its introduction, Federov et al. [Fed+07] reported
that Blebbistatin does not affect the cardiac electrophysiology. After that,
multiple studies confirmed the similar findings.
Though the variations in electrophysiological parameters in contracting
versus Blebbistatin-uncoupled hearts are significant, as visible in Figure 5.3
the action potentials becomes triangular at higher frequencies in contracting
conditions. This indicates that heart becomes ischemic (reduction of oxygen
and nutrients to the heart muscle) at this pacing frequencies. Recent study
by Kuzmiak-glancy et al. [Kg+15] shows a correlation between shortening
of action potential duration and higher metabolic demand and oxygen con-
sumption of the hearts. Hence, the observed differences between contracting
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and Blebbistatin-uncoupled hearts might not be the direct effect of Blebbis-
tatin, but might be an indirect effect since the metabolic demand and oxygen
consumption are lower in Blebbistatin-uncoupled hearts.
7.1 Limitations
One of the major limitations is that optical recordings used in this thesis were
performed only with a single camera. Hence, it was not possible to image
the entire surface of the heart. Only 60-80% portion of the left ventricular
surface (2-3 cm) was imaged in all the experiments. This was due to the
fact that only limited number of high power LED sources were able to use
owing to the limitation in the maximum voltage which the LED driver can
supply (45 V for each channel). Hence, only 6 high power LEDs (3 blue and
3 green) were used in the whole experiment.
Eventhough the combination of motion tracking and excitation ratiometry




Fig. 7.1: Exemplary time traces showing residual motion artifacts in optical action
potentials of a rabbit heart in contracting condition. Action potential time
traces are obtained from the left ventricular surface with spatial averaging
of 3× 3 pixels. Time traces are normalized using a sliding window. Action
potential traces in contracting condition shows severe baseline fluctuations
as compared to Blebbistatin condition.
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it also has some limitations. The inability to measure action potential dura-
tion at 90% repolarization APD90 (considered as standard measurements in
Blebbistatin-uncoupled hearts) from contracting hearts at all pixel locations is
one of its drawbacks. This is due to the presence of residual motion artifacts
(for some pixels) in the action potential signals even after applying motion
tracking and ratiometry. One such example is shown in Figure 7.1. The
severe base line fluctuations of the time traces due to residual artifacts cause
inaccuracy in the measurement of APD90 in contracting condition.
Moreover, temporal resolution of the recorded action potential signals is
half of the camera frame rate. This is due to the separation of recorded
video frames (500 fps) into action potentials corresponding to blue and green
excitation light (250 fps). These lowered temporal resolution can cause mild
inaccuracy in the calculation of parameters such as action potential duration.
7.2 Outlook
Multiple LED switching boxes can be used in synchrony to produce more
blue and green LED light sources which can be switched with each camera
frame. This will allow excitation ratiometric measurements of optical action
potential signals from the entire surface of the heart.
Replacing the excitation ratiometry with emission ratiometry can signifi-
cantly reduce most of the motion artifacts originating from dye concentration
and illumination inhomogeneity since in this case the optical mapping exper-
iment uses single fluorescent dye and a single excitation wavelength. In this
case, two cameras with different emission filters have to be aligned to image
same location of the cardiac tissue.
While performing experiments with Langendorff perfused contracting
hearts, it is necessary to improve the Tyrode’s solution to compensate for
the higher metabolic demand and oxygen consumption. Hence in future
experiments, perfusate having higher oxygen carrying capacity such as whole
blood or perfusate supplemented with red blood cells (RBCs) could be used
to address the oxygenation problem of contracting hearts [Kg+15].
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